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Quantitative dynamische kontrastverstärkte Perfusions MRT - eine Phantom- und in
Vivo Studie Die Quantifizierung der Gewebeperfusion mit der Magnetresonanztomographie
(MRT) ist von großem medizinischen Wert für die Tumordiagnose, die Behandlungsplanung
und die Therapiekontrolle. Ziel dieser Arbeit war es, die Durchführbarkeit der Perfusionsquan-
tifizierung mit Hilfe der dynamischen kontrastverstärkten (DCE) MRT in Kombination mit phar-
makokinetischer Modellierung zu evaluieren sowie Limitationen und Verbesserungen zu finden.
Im ersten Teil wurde ein multimodales Perfusionsphantom entwickelt, das die menschliche
Physiologie auf Kapillarebene nachahmt und den intra- und extravaskulären Raum simuliert.
Dies ermöglicht die Anwendung eines Zwei-Kompartiment-Modells, das zu Perfusionsparame-
tern führt, von denen unter anderem der Plasmafluss PF sowohl innerhalb einer Messreihe (PF
= (91 ± 7) ml/100 ml/min) als auch in der Wiederholung nach einer Woche (PF = (91 ±
26) ml/100 ml/min) reproduzierbare Werte zeigt. Ein zuverlässiger Vergleich ist nicht nur zwi-
schen MRT und DCE-Computertomographie (CT) (PF = (94 ± 53) ml/100 ml/min), sondern
auch zur alternativen MRT-Perfusionstechnik Arterial Spin Labeling (ASL) (PF = (99 ± 36)
ml/100 ml/min) möglich. Eine schnelle zeitliche Auflösung durch eine hohe Abtastrate, die
für eine exakte Modellierung unabdingbar ist, wurde durch die Implementierung der paralle-
len Bildgebung erreicht und führte zu einer signifikanten Reduktion der Abweichung innerhalb
einer Messung um 30%. Im zweiten Teil zeigte eine in vivo-Perfusionsstudie von Rektum Karzi-
nomen, dass die bilaterale Auswahl der arteriellen Eingangsfunktion und die Verwendung von
Zwei-Kompartiment-Modellen einen signifikanten Einfluss auf die Quantifizierung der Perfu-
sionsparameter mit Abweichungen des PF von bis zu 30 ml/100 ml/min haben. Die Bedeutung
der Auswahl des Gewebebereichs bei heterogenen Tumoren wurde gezeigt, da sich die Parame-
ter innerhalb eines Tumors um bis zu 36% unterscheiden. Die Kombination der Ergebnisse aus
der Phantom- und der Patientenstudie zeigt somit neue und vielversprechende Strategien zur
Quantifizierung der DCE-MRI in der Zukunft auf.
Quantitative Dynamic Contrast-Enhanced Perfusion MRI - A Phantom and in Vivo
Study The quantification of tissue perfusion with magnetic resonance imaging (MRI) is of
great medical value for tumor diagnosis, treatment planning and therapy control. The aim
of this work was to evaluate the feasibility as well as to find limitations and improvements
of perfusion quantification using dynamic contrast-enhanced (DCE) MRI in combination with
pharmacokinetic modeling. In the first part, a multimodal perfusion phantom mimicking hu-
man physiology at capillary level and simulating intra- and extravascular space was developed.
This enables the application of a dual compartment model leading to perfusion parameters of
which among others the Plasma Flow PF shows reproducible values both within a series of
measurements (PF = (91 ± 7) ml/100 ml/min) and in the repetition after one week (PF =
(91 ± 26) ml/100 ml/min). A reliable comparison not only between MRI and DCE computer
tomography (CT) (PF = (94 ± 53) ml/100 ml/min), but also to the alternative MRI perfu-
sion technique Arterial Spin Labeling (ASL) (PF = (99 ± 36) ml/100 ml/min) is applicable.
Fast temporal resolution through a high sampling rate, indispensable for exact modeling, was
achieved by the implementation of parallel imaging and led to a significant reduction of the
intra measurement deviation by 30%. In the second part, an in vivo perfusion study of rectal
carcinomas showed that the bilateral selection of the arterial input function and the use of dual
compartment models have a significant influence on the quantification of perfusion parameters
with deviations of the PF of up to 30 ml/100 ml/min. The importance of tissue ROI selection
in heterogeneous tumors has been shown, as the parameters within a tumor differ by up to
36%. The combination of the findings of the phantom and the patient study reveals new and
promising strategies for quantifying DCE-MRI in the future.
v
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Introduction1
Magnetic resonance imaging (MRI) is a powerful non-invasive and radiation-
free medical imaging technique known for its excellent soft tissue contrast.
Its versatile contrast-creating mechanism has made a variety of MRI imaging
techniques such as functional imaging possible. In contrast to morphological
imaging, which provides information about anatomy, functional imaging can
represent tissue physiology such as diffusion, oxygenation and perfusion. The
development of new scanner hardware and faster imaging methods in recent
years have made functional imaging even more feasible not only for static body
regions such as the the brain, but also for abdominal imaging, despite organ
movement.
This thesis deals with the technique of perfusion imaging in MRI. Perfusion
generally describes the process of supplying oxygen and nutrients to the cap-
illary bed of a particular tissue and supports the removal of metabolic waste
products. Thus, it provides information about the condition of the organ and
often indicates impaired function or vascular diseases. Possible clinical applica-
tions of perfusion measurements include ischemia, cardiac infarction or epilepsy
and, as it detects changes in blood flow and blood supply, targeting of tumor
areas. Although several techniques for measuring perfusion have been devel-
oped, they are all based on the tracking and monitoring of a specific indicator
or tracer in the form of a bolus. For instance, single-photon emission computed
tomography (SPECT) and positron emission tomography (PET) use tracers
that emit photons and positrons, iodinated contrast agents (CA) are used to
change the beam attenuation in the CT. However, the methods mentioned
above include either the use of radioactive substances or X-rays.
Tissue perfusion and permeability can be measured non-invasively by dynamic
contrast enhanced (DCE) MRI (Brix et al., 1991). A bolus of paramagnetic
CA is injected as a tracer for the determination of hemodynamic parameters
by analyzing the signal variation with respect to time. This method enables
the determination of quantitative microvascular parameters such as blood flow,
blood volume, transit time and the permeability from arteries into tissue (Koh
et al., 2011). These parameters can then support the differentiation of malig-
nant and benign tumors (DeVries et al., 2014; Oberholzer et al., 2013) or the
evaluation of tumor response after therapy and also possibly predict therapy
outcome (Ceelen et al., 2006; Zahra et al., 2007).
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However, quantitative dynamic perfusion measurements are not yet fully es-
tablished in the clinical routine. Reproducibility and comparison of quantitative
parameters is difficult due to non-standardized examinations and data analy-
sis (Zöllner et al., 2016a). For this reason, quantification is often omitted for
a faster but less powerful qualitative or semiquantitative evaluation method.
This is regrettable precisely because no or hardly any additional measuring time
would be required for a quantitative evaluation of the necessary data, whereas
the information content of the individual measurement could be massively im-
proved.
The steps required are the rapid measurement of time-variable changes in T1
relaxation times and the use of kinetic modeling processes with accurate deter-
mination of the arterial information, analysis software that allows the input of
various MRI devices and validated statistical tools for the evaluation of tissue
heterogeneity (Khalifa et al., 2014). Highly specific approaches to solve some
of these challenges have already been published. However, most of them are of
theoretical nature (Yankeelov et al., 2005), validated by simulation (Ning et al.,
2018) or have not been integrated into the clinical process but have only been
considered in an isolated setting (Otazo et al., 2010). Furthermore, the lack of
a gold standard for the determination of perfusion values makes the evaluation
of new methods difficult. PET scanning with 15O-labeled water (Detre et al.,
1992) so far represents a form of gold standard. However, due to its high inva-
siveness caused by the radioactive tracer and its short half-life, it is rarely used
in practice.
Research in this thesis was pursued in two directions in order to investigate
the feasibility of quantification, detect limitations and develop improvements.
In the first part, a perfusion phantom setup was developed and in the second
part, a retrospective rectum cancer perfusion study was analyzed.
Part 1: Perfusion phantom setup
Quantification of perfusion data from DCE MRI is of high interest e.g. for
comparison between patients, different measurements and machines. Studies
to validate new methods need to be carried out. However, due to the admin-
istration of CA, volunteer studies are ethically difficult to realize. In patients,
previous diseases lead to a lack of ground truth data, which makes compar-
ative measurements difficult. In previous studies, simulations (Zwick et al.,
2010) and ex-vivo measurements with organs (Sauerbrey et al., 2014) were
done. However, these approaches either do not provide experimental data or
the measurement setup is relatively complicated and reproducibility is limited.
Therefore, phantoms are employed to investigate the reproducibility of perfu-
sion parameters by imitating tissue on a capillary level. Compared to previously
presented phantoms modeling solely the capillaries (Gaass et al., 2017; Knight
et al., 2017), it is proposed to use of a dialysis filter that has a semipermeable
capillary membrane which can be crossed by MR CA in this study. This way,
a dual compartment model (2CM) that represents anatomical conditions more
accurately by simulating intravascular and extravascular space can be applied.
3The aim is to establish a quantitative, reproducible workflow to ensure compar-
ison and standardization of perfusion measurements using DCE MRI.
Initially the feasibility of the phantom was tested. The material properties
were examined during the measurement to ensure that the CA can move as
expected. The distribution of CA in the experimental setup was observed with
the aim to determine arterial input functions (AIF) and tissue signal curves.
Fitting the dual CM on the perfusion signal allows the pixel wise calculation of
perfusion maps describing the plasma flow (PF), the plasma volume (PV) and
the mean transit time (MTT). Furthermore, the permeability, i.e. the exchange
characteristics between the two chambers across the membrane in the form
of extraction fraction (EF) and permeability surface area product (PSAP) can
be investigated and the calculation accuracy can be determined. In contrast
to other phantoms, the setup offers the possibility to repeat the measurement
several times consecutively during a measurement cycle and after several days
without any changes in the tissue structure. The reproducibility of these two
scenarios was evaluated using the perfusion and permeability maps.
The quality of the AIF and the goodness of the CM fit is severely affected by
the temporal resolution Ts of signal sampling, especially when applying phar-
macokinetic models. It is commonly recommended that Ts should be smaller
than 10 s (Shukla-Dave et al., 2019); yet, no consensus on the optimal Ts
exists. In order to increase the sampling resolution, accelerated parallel acquisi-
tion technique (PAT) can be used. However, a compromise between acquisition
speed and image quality must always be found, since the signal to noise ratio
(SNR) decreases with greater parallelization (Li et al., 2012). It was therefore
examined in more detail how parallel imaging affects the two opposite effects
of higher sampling rate and deterioration due to SNR loss on the calculation of
the perfusion parameters.
A comparison with other perfusion measurement methods was pursued as an
alternative to the missing gold standard. The phantom construction was chosen
to ensure suitability for Arterial Spin Labeling (ASL), an alternative technique
to determine the PF in MRI (Petersen et al., 2006), and dynamic contrast en-
hanced Computer Tomography (CT).
ASL does not require an external administration of CA. Therefore its use can
be beneficial in certain circumstances, e.g. intolerance of CA. In fact, ASL is
indeed often used for brain measurements, but much more complicated to use
in the remaining body parts. A comparability of both the DCE MRI and ASL
technique would be particularly useful for follow-up measurements, but is not
yet clinically available.
Also dynamic contrast enhanced computer tomography (CT) combined with
tracer kinetic modeling allows for the determination of quantitative perfusion
parameters. CT perfusion measurements have not played a relevant role in the
past due to high dose levels. However, new technical developments are now
making them more and more conceivable. Increased speed of data acquisition as
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well as modern imaging technologies both are contributing to the reduction of
the required radiation dose (Miles et al., 2012). The advantage of CT perfusion
values is their robustness and reproducibility due to the linear signal intensity
characteristics of the Hounsfield (HU) scale. For financial reasons or due to
incompatibilities with CA or other pathologies, the CT and MRI measurements
are sometimes interchanged for the same diagnosis in everyday clinical prac-
tice. A comparability between the two modalities is, however, not yet given.
In a few studies, results were compared retrospectively, however no standard-
ized procedures to acquire and evaluate MRI and CT data are used (Eastwood
et al., 2003; Fieselmann et al., 2011). Comparisons have also been made in
phantom studies, but few with quantitative evaluation using a phantom with
two compartments (Otton et al., 2013). Since these are particularly suitable
for the description of the tissues physiology, the perfusion phantom was used
in CT where feasibility and reproducibility was investigated and in a last step
compared with the results obtained in the MR measurements.
Part 2: Retrospective Rectum Cancer Perfusion Study
DCE perfusion measurements in patients with rectal cancer are employed in
clinical routine to acquire pretreatment scans (DeVries et al., 2001). It has
achieved broad acceptance not only for local staging of primary rectal can-
cer prior to treatment but also to predict treatment outcome (Attenberger
et al., 2014). Recently, several authors have demonstrated the additional value
of functional MRI parameters comprising perfusion parameters such as PF or
MTT (Koh et al., 2013). However, such quantitative analysis underlies the
well-known issues related to perfusion imaging (Oberholzer et al., 2013), espe-
cially with regard to correct modeling of the pharmacokinetics.
Particularly, selecting an adequate AIF is critical to obtain accurately calculated
parameters (Calamante, 2013). The selection of the AIF becomes essential for
rectum imaging since on the one hand both left and right iliac arteries supply
the rectum and thus the tumor with blood, contributing to the perfusion. On
the other hand stenosis in these arteries is commonly reported, affecting physi-
ology and thus blood supply. Recent studies neglected this problem and rather
just selected either left or right supplying vessel in one of the rectum supplying
arteries or its branches in their analysis (Attenberger et al., 2014), (Koh et al.,
2013), (Oberholzer et al., 2013). The influence of selecting the AIF in either
left or right iliac artery on parameters obtained by perfusion analysis was inves-
tigated with three different pharmacokinetic approaches: a model independent
algorithm, and two different CM.
DCE MRI combined with tracer kinetic modeling allows for the determina-
tion of quantitative perfusion parameters. Either semi quantitative analysis
(Kremser et al., 2007), the model free deconvolution algorithm (Østergaard
et al., 1996b) or the Tofts-model (Tofts, 2010) has been applied in literature,
the latter one is most widely used in clinical routine (Ceelen et al., 2006; Tong
et al., 2015). However, these approaches either do not model the structure
of the tissue (deconvolution) or are limited by not directly providing values for
PF and MTT (Tofts model). In contrast, multi-compartment models can fulfill
5these requirements (Sourbron, 2010). The selection of an adequate pharma-
cokinetic model is crucial to derive the correct perfusion information from the
image data to understand microvascular physiology (Donaldson et al., 2010).
Currently, there is no systematic method for the identification of the most spe-
cific model with regard to clinical usefulness (Ingrisch and Sourbron, 2013).
It is therefore important to compare existing models and assess their quality
in describing the acquired signal. The aim of this study was to compare the
fast deconvolution approach (FD) (Østergaard et al., 1996b) as a model free
method to two different compartment models, the dual compartment uptake
model (2CU) and the dual compartment exchange model (2CX) with regard to
the impact on perfusion parameters.
Tumor tissue is often heterogeneous, the form of heterogeneity is decisive for
the further therapy decision (Sanghera et al., 2012). Yet, most perfusion MRI
studies currently focus exclusively on one specific slice of the tumor for param-
eter calculation (Koh et al., 2013), differing pathologies in other parts of the
tumor may not be detected. Furthermore, the choice of one particular slice de-
pends on the performing physician. Luckily, 3D perfusion MR imaging data is
often already available enabling volume-resolved quantitative parameters map-
ping. In the aim of a better treatment prediction, the influence of volume based
evaluation of perfusion parameters of the rectal tumor compared to the data
obtained by selecting a single slice was investigated.
For analyses on patient data the same issues apply as described above for
phantom measurement: the lack of a gold standard. DCE CT is applicable
to rectal cancer patients as shown in several studies (Koh et al., 2013; Sahani
et al., 2005). Thus a retrospective study in which CT perfusion data were also
acquired within a comparable time frame was chosen for this thesis. These were
evaluated as similarly as possible to achieve a comparison in quantification with
DCE imaging of the rectum.

Theoretical Background2
Perfusion imaging in this thesis is performed with the imaging modalities MRI
and CT. Both enable quantitative measurements of morphological and func-
tional tissue characteristics providing information about the tissue physiology.
This enables the examination and differentiation of diseased tissue and subse-
quent therapy planning. MRI is based on the principle of Nuclear Magnetic
Resonance (NMR), which will be explained in the first part of the following
section. NMR signal generation can be understood using the quantum me-
chanical description of spins and nuclear magnetism. The signal is created by
stimulating the spin system with matching radiofrequency waves in a magnetic
field. This procedure has been further developed to obtain medical information
from the tomographic imaging technique MRI by spatially encoding the origin
of the measured signals. The fundamentals of MR sequences for signal gener-
ation and location as well as contrast generation are explained in the second
part. In CT, on the other hand, the different absorption characteristics of X-
rays in various tissues in the body are used to generate tomographic images
using complex reconstruction techniques which are introduced thereafter. The
two imaging techniques offer specific advantages and disadvantages in both
general and perfusion imaging. The background of perfusion imaging, various
techniques and the standard workflow in both modalities are briefly introduced
in the last part of this theoretical background chapter.
2.1 Nuclear Magnetic Resonance
NMR is based on interactions of protons and other nuclei with a magnetic field.
These nuclei possess an intrinsic nuclear spin, a fundamental physical property
used for signal acquisition. Showing this in an experiment, Bloch et al. (1946)
and Purcell et al. (1946) were honored with the Nobel Prize in Physics in
1952. All nuclei with nuclear spin different from zero can be used for signal
acquisition in principle, however the high occurrence of hydrogen in the body
and the physical properties of its nucleus make it the most relevant one for MRI
in the clinical routine. This section gives an overview over the basic principles
of NMR. The reader is referred to the work of Abragam (1961), Haacke et al.
(1999) and Levitt (2001) for a more detailed description.
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2.1.1 Spin and Magnetic Moment
Atomic nuclei are composed of protons and neutrons. These elementary par-
ticles possess a quantum property called spin, which is an intrinsic form of
angular momentum. The respective quantum number is s = 1/2. If a nucleus
has an odd number of protons and/or neutrons, their spins do not cancel each
other out. The nuclear spin ~I is then unequal to zero. The spin is proportional
to a magnetic moment
~µ = γ~I (2.1.1)
with the proportionality constant γ being the nucleus-specific gyromagnetic
ratio
γ = gIµN
~
. (2.1.2)
Here, gI is the element specific gyromagnetic factor or Landé factor and ~ the
reduced Planck constant ~ = h/2pi = 1.0545 ·10−34 Js. The nuclear magneton
µN can be expressed as
µN =
e~
2mp
(2.1.3)
with the elementary charge e = 1.602 · 10−19 C and the proton mass mp =
1.67 ·10−27 kg. Due to the very high natural occurrence in the human body and
the large gyromagnetic ratio of γ = 267.51 · 106 rads·T of the hydrogen nucleus,
it has a good sensitivity and thus offers ideal conditions in NMR experiments.
As the nuclear spin corresponds to an angular momentum, its quantum me-
chanical operator Iˆ fulfills the commutation rules[
Iˆi, Iˆj
]
= i~ ijkIˆk, (2.1.4)
[
Iˆi, Iˆ
2
]
= 0 (2.1.5)
with ijk being the permutation or Levi-Civita symbol. Since Iˆz and Iˆ2 inter-
change, mutual eigenstates |I,m〉 exist and form a complete basis which is solely
determined by the two quantum numbers I and m. The derived eigenequations
are
Iˆz|I,m〉 = ~m|I,m〉 (2.1.6)
Iˆ2|I,m〉 = ~2I(I + 1)|I,m〉. (2.1.7)
The nuclear spin quantum number I describes the permitted spin states of
the nucleus that are I = 0, 12 , 1,
3
2 , . . . and for hydrogen it is I = 1/2. The
magnetic quantum number m describes the spatial orientation in respect to the
z-axis with the values m = −I,−I + 1, ...., I − 1, I. Consequently, the values
m = −1/2 and m = +1/2 can be derived for hydrogen. Thus, for each spin
state I there are generally (2I+1) discrete states of m. Protons therefore have
two spin states: the spin up |1/2,+1/2〉 and the spin down |1/2,−1/2〉 state.
Without an external magnetic field, these eigenstates |I,m〉 are degenerated,
i.e. they share the same energy level.
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2.1.2 Zeeman Effect
If a magnetic flux is present, the degeneration is resolved and the energy states
can be distinguished. Provided that the nomenclature used in NMR refers to
magnetic flux density as magnetic field, the interaction of the nuclear spin with
the applied magnetic field can be described by the following Hamiltonian
Hˆ = −µˆ ~B = −γIˆ ~B. (2.1.8)
If we assume a constant magnetic field in the z-direction ~B = (0, 0, B0), as it
is commonly the case in an NMR experiment, this simplifies to
Hˆz = −γIˆzB0. (2.1.9)
With the previously introduced eigenvalue equation in Equation 2.1.6 and the
time-independent Schrödinger equation
Hˆ|I,m〉 = Em|I,m〉, (2.1.10)
the energy states Em can be calculated
Em|I,m〉 = −γIˆzB0|I,m〉 = −m~γB0|I,m〉. (2.1.11)
The formation of the two separated energy levels E+1/2 (parallel to ~B0) and
E−1/2 (antiparallel to ~B0) due to an external magnetic field is called the Zeeman
effect, depicted in Figure 2.1. The difference in energy between the two energy
states in the hydrogen atom is
∆Em = E−1/2 − E+1/2 = γ~B0. (2.1.12)
The size of the energy gap between the two states is thus proportional to
the applied magnetic field B0. To induce a transition between the higher and
lower energy state, a photon with the energy ~ω must be absorbed or emitted
according to the Planck Einstein relation E = ~ω. Electromagnetic waves
orthogonal to the magnetic field B0 must hence be applied with a frequency
that satisfies the following equation
~ω0 = γ~B0. (2.1.13)
This leads to the equation for the Larmor frequency
ωL = ω0 = γB0. (2.1.14)
It is proportional to the magnetic field strength and the gyromagetic ratio and
at B0 = 3 T the Larmor frequency amounts to fL = ωL2pi = 127.7 MHz.
2.1.3 Macroscopic Magnetization
In order to obtain a measurable NMR signal, a large quantity of protons is
regarded instead of a single one. In a thermal equilibrium, the population
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Figure 2.1: Zeeman energy splitting in a hydrogen atom. By applying an external
magnetic field B0, the previously degenerated energy levels are divided
into two states E+1/2 and E−1/2. The spin up and spin down state
are formed with an energy difference ∆Em, which can be overcome by
photon absorption or emission proportional to the Larmor frequency ωL.
probability pm of the corresponding Zeeman energy states is described by the
Boltzmann statistics
pm =
1
Z
e
− Em
kBT , Z =
I∑
m=−I
e
− Em
kBT (2.1.15)
with kB = 1.38 · 10−23 J/K being the Boltzmann constant. In the next step,
the probabilities for m = ±1/2 and thus the number of spins parallel n↑↑ and
antiparallel n↑↓ to the static field, can be calculated
n↑↓
n↑↑
= e
∆E
kBT = e−
~γB0
kBT . (2.1.16)
It is remarkable that at room temperature and a field strength of B0 = 3 T
only 2 in 105 spins generate a surplus in the parallel state. Solely this small
difference in the occupation probabilities produces the net magnetization M0,
aligned along the external magnetic field, which causes the NMR signal. This
magnetization is described as the average magnetic dipole moment density in a
certain volume V , which can then be transformed with the use of Equation 2.1.5
to
~M = 1
V
∑
protons
µˆz =
1
V
N∑
n=1
γ
〈
Iˆz
〉
n
= Nγ~
V
I∑
m=−I
mpm. (2.1.17)
At body temperatures, kBT  ~ω0 can be assumed. Using this assumption,
the exponential term in Equation 2.1.15 can be expanded in a Taylor series and
Curie’s law is obtained
M0 ≈ N
V
B0
I(I + 1)γ2~2
3kBT
. (2.1.18)
M0 is the net magnetization available for the NMR signal. It is hence pro-
portional to the field strength of the main magnetic field B0, the spin density
ρ = N/V , and to the square of the gyromagnetic ratio γ.
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2.1.4 Radio Frequency Excitation
Nuclear spins in the magnetic field B0 are precessing with the Larmor frequency
and so does their magnetic moment
dµˆ
dt
= µˆ× γ ~B0. (2.1.19)
However, looking at a spin ensemble in thermal equilibrium, the spins are ori-
entated in random directions, showing only a small net magnetization in z-
direction. All other parts add up to zero since the spins have no phase coherence
and thus statistically cancel each other out. There is no transverse magnetiza-
tion and in this condition it is not possible to measure an NMR signal.
An electromagnetic high frequency field, the so called ~B1-field or radio fre-
quency (RF)-field can be applied. It is perpendicular to the net magnetization,
which leads to an energy transfer to the spin system by resonant absorption with
the Larmor frequency. Referring to Equation 2.1.19, the total magnetization
can then be described by
d ~M
dt =
~M × γ
(
~B0 + ~B1
)
. (2.1.20)
Given that the applied high frequency field is a left circularly polarized RF-field
with frequency ω1 in the x-y-plane
~B1(t) =
 B1 cos (ω1t)−B1 sin (ω1t)
0
 (2.1.21)
it leads to
d ~M
dt =
~M × γ
 B1 cos (ω1t)−B1 sin (ω1t)
B0
 . (2.1.22)
The precession of magnetization around the respective magnetic fields ~B0 and
~B1 generates a complicated equation of motion, which can be simplified by
introducing a new reference system. For this purpose a rotating frame with the
direction of the constant magnetic field ~B0 as rotation axis and the rotation
frequency Ω = (0, 0,−ω1) is most convenient
d ~M ′
dt
= ~M ′ × γ
 B10
B0 − ω1γ
 = ~M ′ × γ ~Beff . (2.1.23)
This formula shows that by selecting ω1 = γB0 for the frequency of the applied
~B1-field, the influence of the ~B0-field disappears. There is now a precession
around ~B1 only. In order to tilt the magnetization vector by a specific angle
and thus generate a magnetization in the transverse plane, the RF-pulse must
be applied with a certain strength and duration. This angle is called the flip
angle α
α =
∫ t
0
γB1 dt′. (2.1.24)
12 CHAPTER 2. THEORETICAL BACKGROUND
2.1.5 Relaxation
The magnetization vector can be divided into a longitudinal componentMz and
a transverse component Mxy. The magnetization is only manipulated as long
as the B1-field is switched on. When this field is deactivated, the excitation
stops and the magnetization returns to its initial equilibrium state of the lowest
possible energy. During this time, the spins interact with their environment and
the surrounding spins leading to two effects: The spin-lattice relaxation, also
referred to as T1 or longitudinal relaxation and the spin-spin relaxation, also
referred to as T2 or transverse relaxation.
Spin-Lattice Relaxation
To return to the initial value M0 in thermal equilibrium, an energy transfer
of the spins through interaction in the form of vibrations and rotations with the
surrounding atoms of the proton takes place
dMz
dt =
1
T1
· (M0 −Mz). (2.1.25)
The differential equation can be solved by an exponential function with the
relaxation constant T1
Mz(t) = Mz(0) · e−t/T1 +M0 ·
(
1− e−t/T1
)
. (2.1.26)
The T1 relaxation time depends on the energy transport between spins and the
tissue environment. Therefore it is varying in different kinds of human tissue.
Furthermore, it is influenced by the magnetic field strength B0, as the latter is
related to the Larmor frequency of the spins, which determines the effectiveness
of the energy exchange between spins and the environment. Typical values can
be found in Table 2.1.
Spin-Spin Relaxation
Directly after the excitation pulse, the spins are phase coherent, resulting in
a magnetization component Mxy in the transverse plane. Each spin is exposed
to a locally dependent magnetic field, composed of applied B0-field and mag-
netic moments of other atoms in the surrounding area. These slight differences
in the magnetic field randomly changing over time cause the resonant frequency
of the spins to shift minimally, resulting in an irreversible dephasing of them.
The magnetization component Mxy thus decreases with time which can be
described similarly to the spin-lattice relaxation by
d ~Mxy
dt = −
1
T2
· ~Mxy. (2.1.27)
The solution is an exponential function decay with the spin-spin relaxation time
T2
~Mxy(t) = ~Mxy(0) · e−t/T2 . (2.1.28)
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Table 2.1: Typical relaxation times T1 and T2 of 1H for different tissue types at
magnetic field strength B0 = 3 T published by De Bazelaire et al. (2004)
and Stanisz et al. (2005).
tissue T1 (ms) T2 (ms)
brain - grey matter 1820 99
brain - white matter 1084 69
kidney - cortex 1142 76
kidney - medulla 1545 81
subcutaneous fat 382 68
muscle 900 50
blood 1932 275
Spin-spin relaxation depends mainly on the molecules surrounding the spin sys-
tem and, in contrast to T1, is mostly independent of the magnitude of the
applied magnetic field. The dephasing process of the transverse component of
magnetization is much faster compared to spin-lattice relaxation as shown in
Table 2.1 for typical biological tissues. The course of the magnetization trajec-
tory with the representation of the two magnetization components is given in
Figure 2.2.
In reality, in addition to atomic and nuclear interactions and the associated
relaxation processes, there are always inhomogeneities in the static magnetic
field or differences in susceptibility of nearby atoms causing the dephasing in the
transversal plane to be accelerated. The actual decay constant is then called T ∗2
and is composed of the previously explained T2 effect and the reversible effect
T ′2
1
T ∗2
= 1
T2
+ 1
T ′2
. (2.1.29)
These additional macroscopic field inhomogeneities, however, are static and
can be corrected by applying a 180◦ pulse, which compensates the dephasing
and isolates the T2 effect. A more detailed theoretical description of relax-
ation processes can be found in the Bloembergen-Purcell-Pound (BPP) theory
(Bloembergen et al., 1948).
2.1.6 Bloch Equations
To mathematically represent the initially described interaction of the spins with
the magnetic field but also the interaction of the spins with the environment
due to spin lattice and spin spin interaction, Bloch formulated equations of
motion for the magnetization ~M , the so-called Bloch equations
d
dtMx = γ(
~M × ~B)x − Mx
T2
(2.1.30)
d
dtMy = γ(
~M × ~B)y − My
T2
(2.1.31)
d
dtMz = γ(
~M × ~B)z − M0 −Mz
T1
. (2.1.32)
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Figure 2.2: The relaxation trajectory of the magnetization vector after a 90◦ exci-
tation. The transverse magnetization component Mxy decays with an
exponential function dependent on the relaxation time T2 as described
in Equation 2.1.28, the longitudinal magnetization Mz recovers expo-
nentially to its initial value M0 according to Equation 2.1.26 with the
relaxation time T1. Image adapted from Krämer (2014).
The solutions of the z-component of the Bloch equations can be found in
Equation 2.1.26. The x- and y-components can be combined into a single
component with a real and an imaginary part
M+(t) = Mx(t) + iMy(t) (2.1.33)
resulting in the differential equation
dM+
dt = −
(
iω0 +
1
T2
)
·M+. (2.1.34)
When solving the rewritten M+(t) component, we obtain
M+(t) = M+(0) · e−i(ω0t+ϕ0)−t/T2 (2.1.35)
from which the amplitude |M+(t)| and phase ϕ(t) of the NMR signal can be
extracted
|M+(t)| = |M+(0)| · e−t/T2 (2.1.36)
ϕ(t) = ω0t+ ϕ0. (2.1.37)
2.1.7 Signal Detection
To measure an NMR signal, a magnetization component orthogonal to the
main magnetic field is required. Thus, the magnetization vector is excited to
obtain a transverse component in the x-y-plane. A receiving coil of size ~A can
now be mounted perpendicular to the main magnetic field. The rotating net
magnetization produces a change of the magnetic flux dφdt in the coil which
generates a voltage Uind according to Faraday’s law of induction
Uind = −dφdt = −
d
dt
∫
Acoil
~B d ~A. (2.1.38)
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The signal in the receiving coil and thus the magnetization can be determined
by using the reciprocity law. It states that the reception sensitivity of a coil
corresponds to the magnetic flux density created by the same coil with a unit
current (Biot-Savart law). The voltage induced in the coil is therefore
Uind = − ddt
∫
Asample
~B1 · ~M0 dV. (2.1.39)
The measurement of an NMR signal is possible during the decay of the trans-
verse component as described in Equation 2.1.28. The precession of the mag-
netization in the x-y-plane induces a voltage in the receiving coil. Due to
dephasing of the spins, this oscillating signal decays over time, which is referred
to as free induction decay (FID) proportional to the spin density ρ(~r)
Uind ∝ S(t) = S0 ·
∫
V
ρ(~r)e−iωRFte−t/T2 dV. (2.1.40)
2.2 Magnetic Resonance Imaging
By transferring the NMR phenomenon described above into medical diagnostics,
MRI can provide a non-invasive representation of the internal body structures.
Paul C. Lauterbur and Sir Peter Mansfield received the Nobel Prize for Physiol-
ogy or Medicine 2003 for this development (Lauterbur et al., 1973; Mansfield,
1977). The determination of the spatial position of an NMR signal by addi-
tion of gradient fields as well as mathematical methods for a fast conversion of
NMR signals into image data enabled a spatially encoded representation of the
NMR signal. In the following, the basic principles of MR imaging technology
are described, i.e. the spatial encoding methods, the readout technique and
finally the parameters that are decisive for the image quality.
2.2.1 Spatial Encoding
Gradients
For the generation of an MR image, the NMR signal must be linked to a
point in space. This is referred to as spatial encoding and is made possible by
additional magnetic field gradients ~G superimposed on the main magnetic field.
~G =
(
∂Bz
∂x
,
∂Bz
∂y
,
∂Bz
∂z
)
. (2.2.1)
Thereby it is achieved that the Larmor frequency introduced in Equation 2.1.14
becomes location dependent
ω(~r) = γB(~r) = γ
(
B0 + ~r · ~G(~r)
)
. (2.2.2)
To choose a slice in the object, this relationship is applied for the so-called
slice selection. Positioning within this slice is determined with two independent
approaches, frequency encoding and phase encoding.
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Figure 2.3: Relation of the bandwidth ∆ω of the RF excitation pulse, the gradient
strength in z-directionGz withG1 > G2 and the resulting slice thickness
∆z with ∆z1 < ∆z2. Larger gradient strength thus leads to a smaller
slice thickness.
Slice Selection
A gradient Gz in the same direction as the main magnetic field B0 leads to a
precession frequency dependent on the z-position
ω(z) = γ (B0 +Gz · z) . (2.2.3)
If an RF excitation pulse is applied subsequently, only the spins at the distinct
z-position resonant to the applied frequency are excited. Since no RF excitation
pulse is arbitrarily sharp but rather has a bandwidth of ∆ω, the excited slice
has a thickness of
∆z = ∆ω
γGz
. (2.2.4)
Figure 2.3 shows how the resulting slice thickness ∆z varies with the bandwidth
∆ω of the RF excitation pulse and the gradient strength in the z-direction Gz.
Phase Encoding
After the slice selection has been carried out, the remaining two dimensions
must be encoded. In phase encoding, a linearly varying gradient in the y-
direction Gy is applied in a period τ before the signal readout. The magne-
tization thus receives an additional phase ∆Φ, which varies depending on the
position in y-direction
∆Φ = τ∆ω(y) = τγGyy. (2.2.5)
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Figure 2.4: Slice selection with z-gradient and application of phase encoding gra-
dient in y-direction and frequency encoding gradient in x-direction for
distinct association of local information of the signal.
Frequency Encoding
In order to encode the third spatial dimension unambiguously, the so-called
frequency encoding is used. A frequency encoding gradient Gx, also called
readout gradient, is switched on during the readout. Thus each x-position is
assigned a certain Larmor frequency
ω(x) = γ (B0 +Gx · x) . (2.2.6)
Combining these two approaches results in the scheme illustrated in Figure 2.4.
Phase encoding prior to readout is repeated n times with Gy being incremented
from −Gy to +Gy. This means each line scanned in y-direction has a different
phase gradient superimposed with the frequency encoding information that is
applied during the readout. Important to note: The resolution in y-direction
is thus directly related to the required number of phase encoding steps and
consequently to the measurement duration.
2.2.2 K-Space Sampling
The process of encoding has led to an accumulated signal consisting of indi-
vidual components with different frequencies and amplitudes. To decompose
this complex signal again, a mathematical concept referred to as Fourier Trans-
formation is used which transforms a spatially dependent signal in a frequency
dependent one (Figure 2.5). The wavenumber ~k is defined as
~k(t) = γ2pi
∫ t
0
~G (t) dt (2.2.7)
depending on the gradients used for the spatial encoding. The signal equation
(Equation 2.1.40) can then be rewritten and simplified to
F(S(~x)) = S(~k) ∝
∫
S(~r)e−2pii~k~r d3~r. (2.2.8)
The different frequency-phase patterns in the sample, generated by the gradient
fields, can now be linked to a so called k-space location. The entire k-space
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can be scanned systematically by changing the gradient moment in x- and y-
direction. The use of an inverse Fourier Transformation subsequently allows the
reconstruction of the signal information for each spatial position in the image
F−1(S(~k)) = S(~x) ∝
∫
S(~k)e2pii~k~r d3~k. (2.2.9)
In practice, however, the k-space cannot be sampled continuously but in discrete
steps. For the most common method, cartesian sampling, S(~k) is sampled
with steps of ∆kx in frequency encoding direction and ∆ky in phase encoding
direction. For frequency encoding, a constant gradient Gx is applied for a
period of time ∆tx. During this time Nx data points can be recorded. For
phase encoding, however, the gradient is always switched on for a constant time
ty, but for each line in k-space, the amplitude of the gradient varies resulting
in Ny steps of the increment ∆ky to cover the k-space
∆kx =
γ
2piGx∆tx (2.2.10)
∆ky =
γ
2pi∆Gytx. (2.2.11)
The size of the recorded area of the sample is called field of view (FOV) and is
determined by the width of the sampling steps ∆kx,y in k-space. The spatial
resolution of the final MR image depends on how many sampling steps Nx,y
this FOV is divided into
∆x = 1
kx,max
= FOV
Nx
= 2pi
γGx∆txNx
(2.2.12)
∆y = 1
ky,max
= FOV
Ny
= 2pi
γ∆GytyNy
. (2.2.13)
It is important to set a sufficiently high sampling rate, because according to
the Nyquist sampling theorem the sampling rate must be at least twice the
highest frequency contained within that signal, otherwise under-sampling will
cause image artifacts. Consequently, depending on the desired spatial resolution
and FOV, a certain number of frequency and phase encoding steps is necessary,
which, for the latter, affects the duration of the measurement time. Short
measurement times are crucial in clinical applications. Therefore, a number
of adjustments have been proposed to reduce this time. Here, the individual
regions of the k-space have a major influence. Scanning the center of the k-
space reveals the low frequencies that mainly contribute to the contrast of the
image. In the outer k-space, instead, the high frequencies provide information
about the details of the image. By adjusting the switching of the gradients and
the RF-pulses in their strength and order, arbitrary trajectories can be traversed
in k-space, theoretically. On this basis, a large number of k-space sampling
trajectories were developed, selectable according to the desired measurement
characteristics. A certain type of trajectory is called a sequence and can be
visualized in sequence diagrams for better understanding.
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Figure 2.5: The accumulated signal consisting of individual components (A, B, C)
with different frequencies and amplitudes in the time domain g(f) is
decomposed via a Fourier Transformation to a frequency spectrum G(f)
with delta functions. The frequency of the individual component can
be found on the x-axis, the amplitude on the y-axis. Figure adapted
from Gallagher et al. (2008).
2.2.3 Standard Acquisition Techniques
Spin Echo
The spin echo sequence developed by Hahn (1950) starts with a 90◦ excitation
pulse which is applied simultaneously to the slice selection gradient. This exci-
tation pulse leads to a flipping of the magnetization into the transverse plane.
The spins, initially in phase, begin to change their precession frequency due to
the spin-spin interaction effects described in Equation 2.1.27 and thus get out
of phase. The total magnetization in the transverse plane consequently begins
to decay with T ∗2 . A 180◦ refocusing pulse is therefore applied after TE/2,
which mirrors the position of the individual spins on the x-y-plane. The phase
shift is getting compensated until all spins are back in phase. This event is
called an echo which occurs after the time TE (Figure 2.6). TE is also referred
to as echo time and is defined as the time interval from the excitation of the
sample to the echo. Static inhomogeneities in the main magnetic field and sus-
ceptibility artifacts are compensated by this refocusing technique, therefore the
measured signal only depends on T2. In order to cover the complete k-space,
a further line is recorded after the repetition time TR with changed strength
of the phase encoding gradient. Thus, the desired number of phase encoding
steps determines the duration of the acquisition time.
Gradient Echo
The main difference between a gradient echo sequence and the spin echo se-
quence is the sole use of a magnetic field gradient for echo generation instead
of additionally using a refocusing pulse. After the initial pulse for the gener-
ation of a transversal component, first a gradient is applied, which leads to a
dephasing of the spins. A gradient with exactly the same magnitude but op-
posite polarity then leads to rephasing and thus to an echo (Figure 2.6). Like
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Figure 2.6: Gradient scheme of the spin echo sequence with according k-space tra-
jectory. Together with the slice selection gradient in z-direction, a 90◦
excitation pulse is applied, flipping the magnetization in the transverse
plane. Then phase encoding in the y-direction is applied. Dephasing
due to T ∗2 is reversed by a 180◦ refocusing pulse after TE/2. The inver-
sion of the precession direction leads to an echo at t = TE, the T2 decay
of the signal can be measured. During readout, frequency encoding is
done in x-direction. Scheme adapted from Mie (2011).
the spin echo sequence, each line in k-space must be recorded with a changed
phase encoding gradient. The major advantage of the gradient echo sequence
is the fast switching of the gradients instead of using a long 180◦ pulse. This
makes it possible that a 90◦ pulse is not necessarily used as the initial pulse,
but that angles α < 90◦ are also sufficient to generate a measurable signal
in the transverse plane. Furthermore, one initial pulse can be used to measure
an echo several times by repeating the gradient sequence (Multi Echo). This
also leads to considerable time savings. However, in contrast to the spin echo
sequence, magnetic field inhomogeneities are not compensated. The signal is
thus defined by a T ∗2 decay.
Inversion Recovery
First, the magnetization is inverted by the so-called inversion pulse, a 180◦
RF-pulse that flips the magnetization to point along the negative z-axis. Ac-
cording to Equation 2.1.26, the magnetization is returning to its equilibrium
state depending on the T1 relaxation time of the corresponding tissue. For
signal generation, the existent longitudinal magnetization is rotated into the
transverse plane by means of a 90◦ RF-pulse at a certain point in time and
subsequent echo generation with a 180◦ RF-pulse using the same method as
for the spin echo. The duration from start of recovery until signal readout is
defined as the inversion time TI. The measurement is repeated selecting differ-
ent TIs. This leads to the sampling of the magnetization curve starting with a
negative magnetization and following the recovery until the former positive net
magnetization is reached again.
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Figure 2.7: Gradient scheme of the gradient echo sequence with according k-space
trajectory. A flip angle smaller than α < 90◦ can be applied to create
a transverse magnetization component. It is applied together with the
slice selection gradient in z-direction. While phase encoding is applied
in y-direction, dephasing and rephasing is performed by an additional
gradient in x-direction. Scheme adapted from Mie (2011).
2.2.4 Signal and Contrast
T1- and T2-weighting
MRI is characterized among other things by the ability to achieve good contrasts
in the tissue. In general, the image contrast is determined by T1, T2 and the
proton density (PD). By appropriate selection of sequence parameters, however,
one of the contrasts can be emphasized. By modifying the parameters echo
time TE and repetition time TR, a T1-, T2- or PD-weighted contrast can be
generated. If a short TE is selected, the time of dephasing and rephasing of the
spins in the transverse plane before the signal acquisition is short. Therefore the
influence of T2 is rather small. Conversely a long TE leads to a T2-weighting.
Most MR scans use multiple excitations repeated after TR. A short TR leads to
the fact that the equilibrium magnetization for the next acquisition phase is not
yet completely reached. Tissue with short T1 can already reveal more equilib-
rium magnetization in the same time than tissue with long T1. This is reflected
in the signal intensity and thus leads to a T1-weighting. If, on the other hand,
a long TR is selected, all spins are already in equilibrium during the following
excitation, so the signal becomes T1 independent. In Figure 2.8 these effects
are illustrated by exemplary MR images. Optimum contrast is achieved when
TE and TR are approximately in the order of T2 and T1 respectively. In addi-
tion, several other contrasts can be generated, such as PD-weighted contrast
for long TR and long TE but also other tissue specifications can be emphasized
by setting additional parameters. Susceptibility contrasts as well as diffusion- or
perfusion-weighted images are feasible, all of which can be selected according
to the clinical objective.
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Figure 2.8: T1-, T2- and PD-weighted image of an exemplary sagittal brain slice.
The obtained image contrast is dependent on the duration of TE and
TR.
Image Quality
Image quality does not depend solely on the contrast of the signal. In ad-
dition, there is a statistical noise associated with each physical measurement.
This noise is caused by the measured object and the used electronics and is
reflected, for example, in a deterioration of quantitative measurements. There-
fore it makes sense to consider the signal to noise ratio (SNR) when assessing
the image quality and to take actions for noise reduction, e.g. in hardware
design. The SNR can moreover be influenced by the measurement parameters
as it depends on the imaging time, the readout bandwidth and the resolution.
The SNR of an image decreases with higher spatial resolution, since only a
reduced number of protons can contribute to the signal. This effect has to be
balanced with the increased level of detail achieved by high spatial resolution
and the avoidance of partial volume effects. Partial volume effects occur when
two or more objects are located within a voxel. The measured signal intensity is
then composed of the signal components of the individual objects, their edges
become blurred. Especially when measuring small vessels, as is necessary in
perfusion imaging, it is important to avoid this effect.
2.3 Computer Tomography
With the discovery of X-rays by Röntgen (1896), the foundation was set for
an imaging technique in which the inside of a body can become visible. The
development into a computer tomography system took place several decades
later. Radon (1917) had already provided the mathematical basis for this years
before with the description of the Radon transformation. Cormack (1973) and
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Hounsfield (1973) further developed the filtered back-projection, which allows
cross-sectional images of the human body by means of absorption differences
of X-rays in tissue and subsequent image reconstruction methods. In 1979,
they were jointly awarded the Nobel Prize for Physiology or Medicine. This
section gives a brief overview of the CT fundamentals. Further explanations
are provided by Buzug (2011).
2.3.1 X-Rays
X-rays are generated with an X-ray tube. It emits an X-ray spectrum by stop-
ping the free thermal electrons accelerated from the cathode to the anode.
The emitted radiation consists mainly of Bremsstrahlung, which generates a
continuous radiation spectrum through scattering processes (Figure 2.9). The
so called characteristic radiation are discrete emission lines, generated by de-
tached electrons from the anode material by collision processes. Dropping of
the electrons from the outer shell onto this free space releases a specific energy
that corresponds to the energy difference of the two discrete levels involved in
the transition.
2.3.2 Photon Matter Interaction
The photons penetrating the body interact with it through different physical
processes. The attenuation of the initial intensity I0 is determined by Lambert
Beer’s law
I(x) = I0 · e−µx (2.3.1)
with the attenuation coefficient µ. It is mainly composed of Rayleigh and
Compton scattering as well as the photoelectric effect in medical X-ray imaging.
Rayleigh Scattering
Rayleigh scattering is the elastic scattering of electromagnetic waves by parti-
cles whose diameter is small compared to the wavelength λ, i.e. the scattering
of light at small molecules. An interaction with a bound electron is assumed.
The elastic scattering process preserves the energy of the photon, but since
there is a change of direction, the photon can no longer be used in reconstruc-
tion processes for imaging.
Compton Scattering
Compton scattering describes the scattering of a photon with a quasi-free
electron. However, the collision is inelastic and part of the energy or linear
momentum is transferred from the photon to the electron. The photon with
the remaining energy is then moving in a different direction than the original
one.
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Figure 2.9: X-ray tube and X-ray spectra of a tungsten anode for different anode
voltages with the continuous bremsstrahl spectra as well as the charac-
teristic emission lines (Buzug, 2011).
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Figure 2.10: Superposition of the several absorption processes Rayleigh scattering,
Compton scattering and photoelectric effect leads to the attenuation
profile of X-rays in water. The diagnostic energy window (50-140 keV)
is marked in grey. Image originates from Buzug (2011).
Photoelectric Effect
In addition to the scattering processes of the X-ray quanta, they can also be
completely absorbed. An electron is released from its bond in the atom by
capturing the incident photon. To do this, the photon must have at least the
binding energy of the electron, the remaining energy being converted into ki-
netic energy of the emitted electron.
The described interaction processes and the Lambert Beer’s law in Equa-
tion 2.3.1 lead to the fact that the attenuation on a macroscopic scale depends
on the wavelength λ of the photon and the order number Z, the density ρ and
the thickness x of the absorber. The mass attenuation coefficient in water for
typical clinical photon energies is given in Figure 2.10.
2.3.3 Signal Acquisition
In this first generation of CT devices, the beam emitted by the radiation source
is collimated into a fine needle beam. On the opposite side of the object, a
single detector can measure the attenuated beam. This process is repeated
for different angles and, in order to cover the entire object as efficiently as
possible, the beam is also shifted tangentially. The absorption coefficient is
variable within the object, and the intensity measured by the detector is a
superposition of these attenuations.
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Figure 2.11: Calculation of the Object Space from the Radon Space using the Radon
transformation to obtain a CT image. Using the Fourier-Slice theorem,
the Object space can also be calculated by a one-dimensional Fourier
transformation F1 and an inverse two-dimensional Fourier transforma-
tion F−12 . Image was taken from Buzug (2011).
2.3.4 Image Reconstruction and Hounsfield Units
Image Reconstruction
In the reconstruction process, the inverse problem of determining the voxel-
wise absorption coefficients must be solved. The absorption values are shown
in a sinogram as a function of the angle ξ and the displacement γ which is called
Radon Space pγ(ξ). The Radon Space is linked to the Object Space f(x, y)
via the inverse Radon transformation R−12 . To determine this transformation
mathematically effectively, the Radon Space can first be transferred into the
Fourier Space with a one-dimensional Fourier transformation F1. Afterwards,
applying an inverse two-dimensional Fourier transformation F−12 leads to the
Object Space according to the Fourier slice theorem (Figure 2.11). However,
using this approach, the simple unfiltered backprojection reconstructs positive
attenuation values in image areas that have made no contribution to the at-
tenuation at all. This leads to blurred areas in the reconstructed image. The
incorrect values cannot be compensated by further backprojections. Therefore
the backprojection is extended by a high pass filter, so that the filtered back-
projection can reconstruct the image data correctly. The CT reconstruction is
explained exemplary using the parallel beam geometry here. The mathematical
methods of more modern geometries of CT scanners, for example cone beam
CT, can be obtained from these using suitable coordinate transformations.
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Figure 2.12: CT values in Hounsfield units for different body materials and organs.
Per definition, air is assigned the CT value -1000 and water the value
0. Image adapted from Alkadhi et al. (2011).
Hounsfield Units
For a comparability of the images independent of different acquisition parame-
ters such as tube voltage and beam filtering, the measured attenuation values
µ are normalized. They are converted into CT values, their units are called
Houndsfield units (HU). Per definition, air is assigned the CT value -1000 and
water the value 0
CT value = µvoxel − µwater
µwater − µair · 1000. (2.3.2)
CT values for different body materials and organs can be found in Figure 2.10.
2.4 Perfusion Imaging
In this section, the definition of the term perfusion in general and its theoretical
determination in human tissue is given. Furthermore, the concepts for mea-
suring perfusion with MRI and CT are presented. Over time, two approaches
have emerged. The first approach is based on the injection of a tracer into the
investigated system. It includes dynamic susceptibility contrast (DSC) MRI and
dynamic contrast-enhanced (DCE) MRI. DSC MRI is a T ∗2 -weighted technique
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only used in the brain for the clinical evaluation of perfusion in cerebral ischemia
and brain tumors and will not be discussed further in this thesis. DCE MRI is
the technique this thesis focuses on. It is based on the injection of a contrast
changing material enabling T1-weighted bolus tracking. A second technique
called arterial spin labeling (ASL) uses magnetically labeled water protons in
the arterial blood as endogenous tracers. Perfusion measurements can be per-
formed in CT as well. It is a dynamic contrast-enhanced approach (DCE CT)
based on the injection of a tracer. Research into perfusion imaging has been
carried out in many areas, both from a technical and clinical point of view. A
more detailed insight in the methods relevant for this work will be explained in
the following.
2.4.1 Tissue Perfusion
The term perfusion generally describes the process of supplying oxygen and
nutrients to the capillary bed of a particular tissue. It refers to the delivery of
arterial blood and in MRI and CT is measured in units of milliliters per 100
grams tissue per minute. It is important to distinguish between perfusion in the
capillaries of the tissue and bulk blood flow occurring along the major arteries
and veins. As perfusion is strongly correlated with the supply of oxygen and
other nutrients to the tissues and removal of metabolic waste products, reduced
perfusion often indicates impaired organ function or vascular diseases. Possible
clinical applications include screening for malignant diseases, characterization
of lesions, monitoring of lesion response to treatment and evaluation of residual
pathologies (Hayes et al., 2002; Ross et al., 2002).
2.4.2 Tracer Kinetics
Although several techniques for measuring perfusion have been developed, they
are all based on the tracking of a specific indicator or tracer in the form of a
bolus. Modeling the tracer kinetics provides information about its distribution
in the tissue and thus provides physiological information. It has to be noted
that strictly spoken, there is a difference between the term indicator and tracer
(Sourbron and Buckley, 2013). However, literature conventionally uses the term
tracer in all cases (Lassen and Perl, 1979). The type of tracer is different for
the methods developed so far.
Tracer Kinetic Modeling
The fundamental tracer kinetic model is described by the indicator dilution the-
ory (Meier and Zierler, 1954) based on the assumption of a linear and stationary
system. It is linear if there is a proportionality between the tissue response to
tracer injection and the injected dose at any given time. A stationary system
is independent of the injection time (Sourbron and Buckley, 2011).
Mass Conservation
Mass conservation states that no indicator is created or destroyed inside the
tissue. Consequently, for a tissue with various inlets and outlets the difference
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between total influx Ji and outflux Jo is the change of the tissue concentration
C(t) over time
dC
dt (t) =
∑
i
Ji(t)−
∑
o
Jo(t). (2.4.1)
A link between influx and outflux can be established by the indicator transit
time, defined as the time between entering and leaving the tissue. In an arbitrary
branched tissue the indicator can use multiple paths causing a distribution of
transit times. In a linear and stationary system, this leads to a probability
distribution Hi(t) acting as a propagator through the system (Lassen and Perl,
1979) ∑
o
Jo(t) =
∑
in
Hi ∗ Ji(t). (2.4.2)
Here, the convolution f ∗ g is defined as
(f ∗ g)(t) =
∫ t
0
f(u)g(t− u) du. (2.4.3)
An integration of Equation 2.4.1 and Equation 2.4.2 yields the relationship
between the tissue concentration and the concentrations at the inlets
C(t) =
∑
in
Ri(t) ∗ Ji(t) (2.4.4)
with the definition of the residue function
Ri(t) = 1−
∫ t
0
Hi(u) du or Hi = −dRidt . (2.4.5)
Ri(t) is the proportion of dose injected at time t = 0 remaining in the tissue at
time t. Consequently, R(0) = 1, and R(t) continues to decrease depending on
the tissue and tracer, but always remains positive. Henceforth, the expectation
value of Hi(t) is called transit time Ti of the inlet i.
Ti =
∫ ∞
0
t ·Hi(t) dt =
∫ ∞
0
Ri(t) dt. (2.4.6)
Model Free Analysis
These general theoretical considerations are simplified to a single inlet model
for typical MRI and CT experiments. Equation 2.4.4 then converts into
C(t) = I(t) ∗ ca(t) with I(t) = PF ·R(t). (2.4.7)
The indicator is supplied by an arterial vessel feeding the tissue, whose measured
concentration ca(t) in the blood plasma is also referred to as arterial input
function (AIF). An unknown, tissue specific impulse response function I(t)
then connects the experimentally determinable time curves C(t) and ca(t) by
a convolution. PF describes the plasma flow, i.e. the carrier of the tracer to
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the tissue. To estimate perfusion numbers, the simplest approach is a model-
free analysis, where I(t) is determined by numerical deconvolution of C(t) with
ca(t) (Østergaard et al., 1996a,c). This technique makes no assumptions about
the tissue structure. After I(t) has been calculated, the PF can be determined
directly using R(0) = 1. Alternatively, it is feasible to derive the maximum
value
PF = max(I(t)) (2.4.8)
leading to fewer numerical errors and dispersion of the contrast bolus in practice
(Sourbron et al., 2004).
Compartment Models
Tracer kinetic models are used to incorporate existing information on structure,
physiology and metabolic processes into the evaluation. The so-called compart-
ment models (CM) are based on a tissue description consisting of one (single) or
more (multi) compartments with one or several inlets or outlets. Accordingly,
there is a multitude of possible models with corresponding assumptions and
boundary conditions that can be applied depending on the organ and pathol-
ogy (Ingrisch and Sourbron, 2013; Sourbron and Buckley, 2011). A specific
analytic approach for the determination of the residual function R(t) is chosen,
allowing the determination of further tissue parameters such as the exchange
rate between the compartments or their volume.
A compartment is described as a space in which the tracer concentration within
the distribution volume v is homogeneous yet time-dependent. The concentra-
tion of the indicator c(t) within this compartment is given by the number of
indicator molecules divided by the distribution volume
c(t) = C(t)
v
. (2.4.9)
In addition, it is assumed that the outflow of all outlets must be proportional
to the compartments’ concentration
Jo(t) = Foc(t) (2.4.10)
with the factor of proportionality Fo, the clearance of the system (Lassen and
Perl, 1979). An exchange between the compartments is assumed. The equa-
tion of mass conservation Equation 2.4.1 for a single compartment model then
changes into
v
dc
dt (t) =
∑
i
Fici(t)−
∑
o
Foc(t). (2.4.11)
Solving the differential equation reveals a mono-exponential decrease of the
residual function. The time constant is the mean transit time (MTT), com-
pletely independent of the inlet, hence it does not depend on the entry time of
the tracer. The MTT is determined by the volume of distribution v and the
clearance of the outlets
R(t) = e−t/MTT with MTT = v∑
o Fo
. (2.4.12)
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Figure 2.13: DCE signal over time. A series of images within a short time frame is
acquired. For each voxel, the signal change S(t) caused by the passing
CA bolus can be derived. Figure adapted from Zimmer (2014).
Accordingly, for n interacting compartments, n differential equations are gener-
ated from Equation 2.4.11.
2.4.3 Dynamic Contrast Enhanced Techniques
The idea that tissue perfusion could be measured by injection of an external
tracer and subsequent measurement of the resulting signal changes was first
proposed by Runge et al. (1984) and Pettigrew et al. (1986). In DCE MRI,
the external tracer is injected into a peripheral vein as a bolus, which then
moves through the body within the bloodstream. The distribution of the bolus
is therefore related to the blood supply and the physiology of the investigated
tissue. However, the concentration of tracer cannot be measured directly with
MRI. Instead, the administered tracer leads to changes in the relaxation of the
blood, which in turn leads to a signal change. Imaging with a fast sequence
can produce a movie, a time-resolved image series of the same slice or volume
during the passage of the injected CA. Thus, voxel wise signal curves S(t) in
the tissue of interest are generated (Figure 2.13). The concentration c(t) of
CA can then be determined from these curves. Finally, the kinetic tracer theory
described in subsection 2.4.2 is applied to find a suitable tissue model from
which hemodynamic parameters can be calculated. DCE MRI is currently the
recommended method for perfusion imaging in organs besides the brain (Brix
et al., 2004; Dujardin et al., 2005; Jerosch-Herold et al., 2004).
The DCE technique is also employed in CT. The underlying process is the
same, but the applied CA leads to a changed attenuation coefficient, which
results in a change of the measured signal.
2.4.4 Arterial Spin Labeling
ASL was first proposed in 1992 by Detre et al. (1992), Williams et al. (1992)
and Kwong et al. (1992). This MRI technique is non-invasive and no external
tracer needs to be injected. Instead, tissue perfusion is measured by using water
in the arterial blood itself as an endogenous and freely diffusible tracer.
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Figure 2.14: ASL creates a tag image where, at t = 0, the arterial blood is labeled
by an RF-pulse in a slab proximal to the imaging region (green). After
the inflow time TIF, a second image is acquired when the tagged blood
(yellow) reaches the imaging slab (red). Additionally, a control image
is taken where the magnetization is not excited (blue). The ASL signal
is achieved by subtraction of the control image from the tag image at
t = TIF representing the magnetization created by the moving spins
during TIF. Image adapted from Petersen et al. (2006).
To employ arterial blood as a tracer, it has to be labeled in order to differentiate
the tracer signal from the original blood water signal. This is done by inverting
the magnetization of the incoming arterial blood proximal to the tissue volume
of interest. Thus, it is important that these arteries actually supply the region to
be measured afterwards. Subsequently, during the so-called inflow time (TIF) or
post-labeling delay, one waits until the labeled blood traveled from the labeling
to the imaging site. Here the so called tag image is recorded. It has a reduced
magnitude due to the delivered inverted magnetization, i.e. the labeled arterial
blood water. A control image without any signal preparation is also acquired.
It is assumed that the static components are equal both in the tag and in the
control image. The difference between these two ∆M = tag− control is thus
only the signal of the labeled blood which has flowed into the tissue during TIF
and is called perfusion-weighted image. Since this signal change is typically
only 0.5 % - 1.5 % of the total signal, several tag and control pairs are typically
recorded and averaged to increase the SNR of the acquisition. In the following,
two sequences with different principles of the MR signal labeling are described.
Continuous ASL
Detre et al. (1992) and Williams et al. (1992) first established the so-called
continuous arterial spin labeling (CASL). An RF inversion pulse is applied con-
tinuously in the labeling slice with a typical pulse duration of approximately 2
- 4 s. To do this, a magnetic field gradient is applied in the direction of the
flowing arterial blood. This causes the resonance frequency of the magnetized
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Figure 2.15: Pulsed ASL (PASL) uses a short inversion pulse and a larger labeling
region compared to continuous ASL (CASL) which applies a continu-
ous RF-pulse with a low amplitude in a small labeling region. Imaging
starts after the inflow time (TIF ). Figure adapted from Gregori (2009).
hydrogen atoms to slowly change and eventually invert as they flow through the
labeling slice. This inversion technique is also known as flow-driven adiabatic
inversion (Dixon et al., 1986).
Pulsed ASL
Edelman et al. (1994) suggested to use a short 180◦ RF-pulse with a dura-
tion of 10 ms - 20 ms instead of a long pulse in a thick slab proximal to the
imaging volume. The result, i.e. the inverted magnetization of the blood, is the
same, but due to the optimization of the RF hardware for short pulses rather
than continuous irradiation pulses, a reduced energy deposition in the tissue
is possible. This technique is called pulsed ASL (PASL). Although a higher
labeling efficiency can be reached, the arrival time of the magnetized blood in
the imaging volume varies considerably more due to the thick slab. Thus the
T1 decay also varies and leads to a bias in perfusion measurement.
In current research, attempts are being made to combine both techniques in
order to optimally exploit their advantages, an example of which is the pseudo
continuous pCASL sequence (Dai et al., 2008; Wu et al., 2007).
Perfusion measurements with ASL can be quantified. In Buxton et al. (1998)
the general kinetic model (GKM) is introduced, which combines physical pro-
cesses like longitudinal decay and bolus length with mathematical models.

Materials and Methods3
The first section of this chapter describes the technical specifications of the
imaging modalities MRI and CT relevant for this work. This is followed by
a presentation of the measurement and evaluation methods of the individual
experiments regarding the perfusion phantom study and the retrospective pa-
tient study of perfusion in rectal cancer patients. Sections of the latter have
been published in (Gaa et al., 2017) and the description of the corresponding
methods is presented here.
3.1 DCE MR and CT Imaging
The DCE imaging technique requires several procedures reaching from calibra-
tion to image acquisition and analysis. The specific methods that have been
applied in this thesis to implement them will be further explained in the following
(Figure 3.1) .
3.1.1 MR Scanners and Coils
MR Scanners
The MRI measurements were carried out at the Department of Clinical Ra-
diology of the University Hospital Mannheim. Clinical 3 T full-body scanners
(MAGNETOM Tim Trio and MAGNETOM Skyra, Siemens Healthineers, Erlan-
Figure 3.1: Schematic visualization of the operating steps for DCE imaging: CA
calibration, image acquisition and data analysis.
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Figure 3.2: 3T MR scanners (a) MAGNETOM Tim Trio and (b) MAGNETOM
Skyra (both Siemens Healthineers, Erlangen, Germany) used for patient
and phantom measurements. In picture (a) the automatic CA pump is
visible.
gen, Germany) were used (Figure 3.2). The static main magnetic field in both
scanners is generated by superconducting coils cooled with liquid helium. In the
bore of the scanner, the gradient system and transmitting coils are included.
Also, the system is equipped with shim coils that ensure the homogeneity of
the main magnetic field. This means that the B0-field is adjusted by active
shimming before the scan.
The MAGNETOM Tim Trio system length is 2.13 m with a bore diameter
of 0.60 m. A maximum gradient amplitude of 40 mTm with a maximum gradi-
ent system slew rate of 200 Tm·s (Siemens, 2004) is permitted. The maximum
possible FOV amounts to 0.50 m · 0.50 m · 0.45 m.
The MAGNETOM Skyra system length is 1.73 m with a bore diameter of
0.70 m. A maximum gradient amplitude of 45 mTm with a maximum gradient
system slew rate of 200 Tm·s (Siemens, 2012) is permitted. The maximum pos-
sible FOV amounts to 0.50 m · 0.50 m · 0.45 m.
MR Coils
The 32-element spinal matrix coil system installed in the patient table was
used for signal reception. Besides, specific receive coils were employed. Pa-
tient measurements were performed with a flexible surface coil (Rx Body18)
that could be placed directly on the patient’s abdomen. Phantom measure-
ments have been performed with a 15 channel phased array knee coil (TxRx 15
channel knee) to optimally enclose the phantom (Figure 3.3).
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Figure 3.3: (a) Flexible surface coil (Rx Body 18) for patient measurements and (b)
15 channel phased array knee coil (TxRx 15 channel knee) for phantom
measurements.
3.1.2 MR Sequences
TWIST Sequence for DCE MRI
In DCE imaging, a series of images are taken over a short time interval to
represent the passage of the contrast bolus. This results in a trade-off between
good spatial imaging of the tissue and a high temporal resolution, ensuring the
best possible sampling of the contrast bolus signal. For an enhanced spatial
resolution, the sampling density of the k-space points in conventional k-space
imaging would be increased. This, in turn, is associated with an extended mea-
surement time, in contradiction to a high temporal resolution.
The gradient echo sequence described in subsection 2.2.3 remains the fun-
damental sequence to fulfill these requirements. It offers the possibility for very
short TRs and TEs, low flip angles, and parallel image acquisition. In addition,
one can benefit from the fact that information about image contrast can be
found in the center of the k-space, while edges and details are encoded in the
periphery as described in subsection 2.2.2.
In DCE MRI, this was first used with a method known as keyhole imaging de-
veloped by Van Vaals et al. (1993) for measuring perfusion data of tumors and
vascular lesions. In the rectangular k-space grid, the central phase-encoding
lines were measured with a higher sampling rate than the outlying k-space
points. This results in a series of highly time-resolved images with satisfactory
spatial resolution.
Further modification led to the TWIST (time-resolved imaging with stochastic
trajectories) (Vogt et al., 2007), (Song et al., 2009) sequence applied in this
thesis. This 3D gradient echo sequence contains a phase encoding plane in ky
and kz direction and frequency encoding in kx direction. The sampling points in
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Figure 3.4: Illustration of the TWIST sequence: The 3D k-space is divided into two
regions. The inner part A of the k-space is completely sampled for each
image. In the outer region B only a fraction (B1, B2, B3) is measured.
The missing part is completed by previous or subsequent measurements
of the dynamic measurement series.
the phase encoding plane are sorted according to their radial distance r and an
azimuth angle ρ from the center. Then, the k-space is divided into two regions:
the inner region A, within a certain radial distance rc, providing contrast in-
formation, and the outer region B, which contains high-frequency information.
The entire k-space is only sampled in the first acquisition of the dynamic series.
For each additional image all points located in region A are sampled but only
a fraction of B (Figure 3.4). Sampling is semi-randomized alternating between
the two regions starting at the outer edge of A. The missing information from
the non-sampled k-space lines in B is obtained from the previously or subse-
quently acquired images. It is assumed that the contrast in the dynamic images
changes as the CA flows through them, but not the information about edges
and details in the periphery of the k-space.
Parallel Imaging
Parallel imaging or parallel acquisition technique (PAT) is another method to
increase the acquisition speed. Multichannel or phased array receive coils are
implemented to simultaneously acquire data. Initially, this leads to an increased
SNR (Roemer et al., 1990). Besides, the individual receiving coil elements have
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Figure 3.5: Principle of parallel imaging with GRAPPA reconstruction. By selecting
an acceleration factor of PAT = 2, only every second line of the k-space
is acquired. The autocalibration signal (ACS) supplies the weighting
factors of each coil for the reconstruction of missing lines. Figure from
Griswold et al. (2002).
different spatial dependent sensitivities. This allows reducing the number of
phase encoding steps while the missing information is compensated by the ad-
ditional data of the receiving coil elements. Undersampling of the k-space
reduces measurement time, for example for a cartesian acquisition scan time is
linearly proportional to the number of phase-encoding steps.
The algorithm applied in this thesis is called generalized autocalibrating par-
tially parallel acquisitions (GRAPPA) (Griswold et al., 2002) and is visualized in
Figure 3.5. The acceleration factor can be selected and indicates which fraction
of the k-space is sampled. It can typically be set between PAT = 2 and PAT
= 6. The FOV and the resolution are preserved by the additional data of the
phased array coils. Before reconstruction, an indirect sensitivity measurement
is performed, which provides further spatial information, the so-called auto-
calibrating signal (ACS). It consists of multiple sampling lines in the k-space
center to determine the weighting of the individual receiving coils. Finally, the
reconstruction is performed for each coil element and assembled with a sum-of-
squares method. The disadvantages of this approach are the reduction of the
SNR and artifacts that can occur during image processing.
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3.1.3 MR Contrast Agent
Mechanism
MR CA is used to increase contrast in conventional anatomical imaging. Fur-
thermore its distribution in tissue provides information on physiological parame-
ters during functional imaging. The MR CAs used in these phantom and patient
studies were Dotarem (Guerbet, France) and Gadovist (Schering AG, Germany).
They both contain the paramagnetic ion gadolinium (Gd) and otherwise differ
only by their manufacturer. Since the Gd ion is toxic to the human organism,
it is embedded in a chelate, diluted and applied intravenously. The seven un-
paired electrons in the outer shell of the lanthanide lead to a faster relaxation
of the surrounding protons causing shorter relaxation times, mainly influencing
T1. This means that the MR signal does not originate directly from the CA but
is indirectly represented by the amount of interaction through chemical bonds
between water protons and the paramagnetic ions (Engelstad and Wolf, 1988).
The concentration of the Gd ion is then inversely proportional to the change of
the relaxation time, predicted by the Solomon-Bloembergen equations (Gow-
land et al., 1992)
C(t) =
(
1
T1(t)
− 1
T10
)
/RGd. (3.1.1)
T10 describes the pre-contrast T1 time and is hereinafter also referred to as
baseline. The proportional constant RGd is called the spin lattice relaxivity of
Gd, dependent on the field strength and chemical structure of the CA and can
be obtained from the CA manufacturer.
The kinetic behavior of a CA in vivo can be determined by connecting CA
concentration changes with changes in the signal of the MR images. In prin-
ciple, the relationship between the CA concentration and the relative increase
in the signal intensity for each image sequence can be derived from the Bloch
equations. First, it should be considered that a linear relationship cannot be
assumed automatically. Therefore, additional calibration measurements are gen-
erally recommended.
Calibration
Consequently, a calibration measurement was carried out as a foundation for
the CA measurements performed in this thesis. The relationship between the
concentration of the Gd containing CA and the measured MRI signal was de-
termined. A phantom consisting of several small tubes with volumes of 50 ml
each was used. A dilution series of different Gd concentrations was prepared.
The samples consisted of dilutions of (0.025, 0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 3.1,
6.3, 12.5, 25, 50) mmol/l (Figure 3.6). They were placed one by one in the
scanner’s isocenter to avoid errors caused by B0-field inhomogeneities. Data
were acquired with a clinical standard gradient echo sequence, parameters are
given in Table 3.1.
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Table 3.1: Imaging parameters of the MR CA calibration measurement.
Sequence TE TR FA matrix size FOV spatial resolution
GRE 10 ms 200 ms 25◦ 128 × 128 (320 × 320) mm2 (2.5 × 2.5 × 2) mm3
Figure 3.6: Calibration of the relationship between the concentration of the CA and
the measured signal. (a) MR measurement of Gd containing tubes with
different concentrations. Note that the tubes were measured subse-
quently to avoid errors caused by B0-field inhomogeneities and (b) CT
measurement of iodine containing tubes with different concentrations.
3.1.4 CT Scanner and Sequence
CT Scanner
The CT measurements were as well carried out at the Department of Clini-
cal Radiology of the University Hospital Mannheim. A dual-source CT system
(Somatom Force, Siemens Healthineers, Erlangen, Germany) was used (Fig-
ure 3.7). At each of the two X-ray tubes, a voltage between 70 and 150 kV can
be set. The detectors are supplied with an anti-scatter 3D collimator grid and
can acquire 192 slices each. A rotation time up to 0.25 s can be reached with
spatial resolutions of 0.25 mm. The gantry opening is 0.78 m. A tin filter shields
patients from clinically irrelevant low-energy radiation which results in less dose.
DCE CT Sequence
Analogous to the DCE MRI measurement, DCE CT measures a series of im-
ages of the selected tissue section over a certain time to track the previously
injected CA bolus. In the acquired image section, the supplying arteries for
the determination of the AIF and the tissue under investigation need to be
displayed. In contrast to MRI measurements, the focus does not lie on find-
ing a compromise between high temporary and spatial resolution. The main
challenge, in this case, is the enhanced dose application to the patient. To
perform DCE measurements, many separate examinations are necessary. They
burden the patient with CA and, for CT, with additional radiation dose, ac-
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Figure 3.7: CT scanner Somatom Force (Siemens Healthineers, Erlangen, Germany)
used for patient and phantom measurements.
cumulating through the dynamic measurement. Only the latest generation of
CT scanners with dose reduction by the tin filter of up to 80 % (Leyendecker
et al., 2019) makes such acquisition possible and ethically justifiable in the first
place. The scanner has an implemented Volume Perfusion CT Body Sequence,
a dynamic shuttle-mode perfusion protocol with automated motion correction
for improved accurate anatomical object alignment. Depending on the patient’s
body weight, tube voltage can be set to the lowest reasonable value of 70, 80,
90 or 100 kVp (peak kilo Voltage). It is important to note that the detector,
therefore, has to be optimized for low photon fluxes.
3.1.5 CT Contrast Agent
Mechanism
The CA Imeron (Bracco Imaging, Germany) used for the DCE CT measure-
ments in the phantom and in the patients in this work is iodine based. In
contrast to MRI, where the paramagnetic ion in the CA acts on the surround-
ing water, CT uses substances that directly attenuate the beam. This requires
a significant difference in their atomic number (number of protons of the el-
ement, Z) to distinguish themselves from other surrounding materials. The
difference to elements naturally occurring in the human body (e.g. hydrogen,
oxygen, carbon, and nitrogen with Z < 10) is large for iodinated CA (Z = 53).
This makes it easy to distinguish them from body tissues based on the spectral
behavior of the materials. In addition, iodine in small quantities is not toxic to
the human body and is easily soluble in water (Laubenberger and Laubenberger,
1999).
The kinetic behavior of the CA in the examined tissue can be determined by
associating the concentration of the CA with the signal intensity. This correla-
tion is much simpler in CT than in MRI. A higher attenuation value, as in the
case of the high atomic number of the CA, is directly linearly related to the
grey values - measured in HU - of the CT images.
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Calibration
A series of measurements were performed to demonstrate the linear correla-
tion described above between the concentration of the iodine containing CA
and the measured CT signal (Figure 3.6). A phantom consisting of several
tubes with volumes of 50 ml each was used. A dilution series of different iodine
concentrations was prepared. The samples consisted of dilutions of (0.01, 0.02,
0.04, 0.08, 0.16, 0.32) mmol/ml. Data were acquired with a standard volume
sequence with lowest tube voltage of 70 kV.
3.1.6 Application of Perfusion Models
Equation 2.4.7 provides the fundament of tracer kinetic calculations of perfu-
sion parameters for the two approaches introduced in this work, the model-free
fast deconvolution approach (FD) and compartment modeling (CM).
AIF
The convolution of the AIF with the residual function indicates that the de-
termination of the AIF plays a central role here. Their exact determination is
necessary to consider the effects of the bolus arrival on the tissue of interest,
e.g. injection rate, cardiac output, arterial condition, the vascular route to the
tissue, etc. These influences should be taken into account beforehand to ensure
no impact on the calculation of specific tissue perfusion parameters.
After the contrast bolus has been administered intravenously, it must travel
through large areas of the body before entering the tissue of interest. The
typical representation of the measured signal curve at one position over time
is often theoretically described by a gamma variation function. It starts with a
relatively flat beginning, the so-called baseline, before the arrival of the CA in
the tissue of interest. It is then followed by a sharp increase up to the maximum
concentration and subsequently a slower decrease called the first passage of the
CA.
However, transport through the body has several effects on its shape, in par-
ticular how and where the measurement of AIF is conducted has a significant
impact. Depending on whether the AIF is measured in a small artery nearby
the tissue of interest or large arteries distal to it, either partial volume artifacts
in small arteries or bolus delay and bolus dispersion effects in large arteries may
occur.
Dual Compartment Exchange Model
In contrast to the model free deconvolution analysis, dual compartment models
assume that the tracer in the tissue can distribute in two separate compart-
ments, the intravascular plasma space and the extracellular extravascular space.
The dual compartment exchange model (2CX) is the most general 2CM that
describes those two separate compartments with the plasma volume PV and
the extracellular extravascular volume EV, respectively. Additional to a single
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compartment model, influx and outflux from the interstitium is taken into ac-
count (Figure 3.8).
The concentration of the CA in the tissue is described as
Ct(t) = PV · CPV(t) + EV · CEV(t) (3.1.2)
where CPV(t), the CA concentration in the intravascular plasma space, is defined
as
dCPV
dt =
PSAP
PV (CEV(t)− CPV(t)) +
PF
PV (Ca(t)− CPV(t)) . (3.1.3)
Ca(t) is the CA concentration in the arterial plasma. The permeability surface
area product (PSAP) describes the in- and outflow rate of the exchange of
the CA between the two compartments. The CA concentration CEV(t) in the
extracellular extravascular space can be obtained by
dCEV
dt =
PSAP
EV (CPV(t)− CEV(t)) . (3.1.4)
Solving Equation 3.1.3 and Equation 3.1.4 yields the bi-exponential tissue re-
sponse function H2CX(t) with function parameters PF, PV, PSAP, EV. Com-
bined with Equation 2.4.7 and the specific impulse response function for the
2CX model, the four parameters PF, PV, PSAP, EV can be determined. For
further details the work of Ingrisch and Sourbron (2013) can be consulted.
Dual Compartment Uptake Model
The dual compartment uptake model (2CU) is a simplification of the 2CX.
If the MTT is long compared to measurement time, efflux is negligible from
EV. Equation 3.1.4 subsequently simplifies to
dCEV
dt =
PSAP
EV (CPS(t)) (3.1.5)
and results in a monoexponential tissue response function H2CU(t). Solving
Equation 2.4.7 with the new tissue response function yields to a three param-
eter model with parameters PF, PV, PSAP. Compared to the 2CX model the
number of model parameters is reduced which means EV is not accessible (Fig-
ure 3.8).
Perfusion and Permeability Parameters
Permeability is the transport rate of the tracer per unit of the capillary surface.
The parameters PF and PV are thus assigned perfusion parameters, whereas
PSAP and EV are referred to as permeability parameters. A simultaneous mea-
surement of perfusion and permeability parameters with the DCE technique
requires the application of a suitable tracer kinetic model to distinguish the
contribution of both spaces. Moreover, a CA exchange between the two spaces
is assumed caused by leakage via the endothelial wall, considered equal in both
directions.
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Figure 3.8: Schematic illustration of (a) the dual compartment exchange model
(2CX) and (b) the dual compartment uptake model (2CU) with param-
eters plasma flow (PF), plasma volume (PV), exctracellular extravas-
cular volume (EV) and permeability surface area product (PSAP). The
CA is transported via the PF and can cross the membrane between PV
and EV. In the 2CU, no efflux from EV is assumed.
Other, sometimes more descriptive parameters can be derived from the pa-
rameters that originate directly from the model. The extraction fraction EF is
the percentage of CA that extravasates and can be calculated by
EF = 1− exp
(
−PSAPPF
)
. (3.1.6)
For reasons of completeness, Ktrans should also be mentioned here, a parameter
used in the Tofts model, measuring the flow into the interstitium (Tofts et al.,
1999).
In literature, the parameters blood flow (BF) and blood volume (BV) are used
instead of plasma flow and plasma volume, also taking the amount of red
blood cells into account. A translation between both conventions can easily
be performed by a scaling factor based on the hematocrit (HCT), the volume
percentage of red blood cells in the blood. It follows that PF = (1−HCT) ·BF.
A HCT = 0.45 was assumed for the studies performed in this thesis. This
corresponds to the human mean and was used, as an exact value was not de-
termined in each patient.
Software and Data Analysis
Standardization of the technical tools is also necessary to advance the quan-
tification of perfusion measurements. To ensure that these can also be used
in everyday clinical practice, user-friendly software certified for diagnosis is re-
quired, additionally enabling the flexible integration of research innovations.
For this reason, the commercial software Osirix (Version 5.6, Pixmeo Inc.,
Genève, Switzerland) and the open source equivalent software Horos (Version
46 CHAPTER 3. MATERIALS AND METHODS
3.0, horosproject.org, USA) was chosen for this work. The DICOM viewer meets
the above mentioned requirements and is used in our Radiology department as
well as by many others worldwide.
The in-house developed and certified perfusion plugin UMMPerfusion (Version
1.5.2) (Zöllner et al., 2016b) allows for executing several DCE MRI perfusion
models simultaneously using the same ROIs during calculations. This is ben-
eficial since the placement of the AIF and tumor tissue ROIs is crucial for a
proper comparison of the models (Calamante, 2013). Furthermore, the selected
signal curves are visualized immediately to directly detect and avoid selection
errors. For compartment models, the plugin also enables an estimation of the
Akaike information criterion (AIC) and chi square χ2 of the fits assessing the
goodness of fit as a parameter for model comparison (Luypaert et al., 2012).
The calculation of hemodynamic parameters is feasible for an averaged ROI
based fit as well as by pixel wise fitting of the corresponding model. For this
purpose, the length of the baseline as well as the HCT and the used slices and
time points can be selected. The boundary conditions for the respective fit can
also be chosen manually.
Consequently, a comparison is possible with the same transparent and repro-
ducible settings. Furthermore, changes or extensions of the plugin can be
integrated reasonably uncomplicated.
Further statistics such as testing for normal distribution and t-test analysis was
performed using MATLAB 2015 (Version 8.1.0.604, the Mathworks, Nattick,
MA, USA).
3.2 DCE Perfusion Phantom Study
A controllable in vitro setup for system calibration, to optimize MRI quantifica-
tion processes such as standardization of the acquisition procedure, as well as
objective evaluation and comparison of pharmacokinetic models was developed.
Therefore, a phantom was designed to generate reference measurements and
ground truth data to assess the reproducibility of measurement protocols.
3.2.1 Phantom Design
As previously proposed by Heilmann et al. (2009) and Rajan et al. (2014), a
hemodialysis filter was used as a basis for the perfusion phantom. The dialysis
filter (Helixone FX 800, Fresenius Medical Care, Germany) was used to imitate
tissue characteristics. It measures 25 cm in length with a diameter of 5 cm.
Inside, it is built up with a bulk of parallel fibers close to the capillary size
(diameter = 200 µm). The construction principle of the dialyzer enables the
transfer of CA through a semipermeable membrane (pore diameter = 1.8 nm)
from within the fibers to the surrounding space and thus provides two com-
partments. It exhibits a fixed permeability of the filter boundary, however the
concentration gradient between the two chambers can be varied (Figure 3.9).
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Figure 3.9: Construction scheme of the dialyzer. Two flow circuits are existent, the
fiber circuit (red) and the dialysate circuit (blue). To simulate tissue
characteristics with two compartments, a dialyzer with a semipermeable
membrane (dashed green line) which can be passed by the CA molecules
(yellow) was used.
Water was pumped from a bucket through an inflow silicone tube of 10 mm di-
ameter (Festo Vertrieb GmbH & Co. KG, Germany) to the fiber compartment
of the phantom. A peristaltic pump (Watson Marlow series 300, Watson-
Marlow Ltd, United Kingdom) was used, which can be set to different pump
rates. In a first step, the pump was calibrated to convert the arbitrary manu-
facturer specification into the actual flow rate, to find the appropriate velocity
for the experiment and to ensure that the pumping capacity is constant. For
this purpose, water was pumped from one reservoir into another at different
set speeds while the time was stopped. The measured values were plotted
against time and the velocities determined using a linear fit. The flow behavior
was observed through the transparent tubes in the realistic measurement setup.
Each time before starting the actual measurement, the phantom was com-
pletely filled with water to make sure that no air is left inside the phantom.
While pumping the water through the tube into the phantom, CA was injected
automatically in the tube by a CA pump approximately 50 cm ahead enter-
ing the phantom when performing DCE measurements. Another outflow tube
lead out of the phantom, transporting the water mixed with CA to a second
bucket. The tube in front of the phantom inlet served as an artificial artery
where the first pass of CA signal was measured and used to determine the AIF
(Figure 3.10). For this purpose, the tube inlet was attached to the phantom
in such a way that it was possible to measure the artificial artery and artificial
tissue in one slice during the subsequent measurement. The second compart-
ment, i.e. the compartment external to the dialysate fibers, can be connected
by an additional circuit for particular experiments. An additional inflow and
outflow tube are therefore connected to the respective connection points of the
dialysis filter (Figure 3.11).
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Figure 3.10: Experimental setup of the perfusion phantom in the scanner room.
Water from the inflow bucket was pumped with a peristaltic pump
into the phantom. CA could be injected automatically. Water mixed
with CA was collected in an outflow bucket.
Figure 3.11: Utilization of the perfusion phantom. Two flow circuits can be ad-
dressed: The fiber circuit (red), with fibers depicted in the cross section
of the dialyzer and the dialisate circuit (blue). The AIF was measured
in the inflow tube shortly before entering the dialyzer together with
the tissue function in the same slice (green).
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Table 3.2: Imaging parameters of the quantitative DCE MRI phantom study.
Sequence TE TR FA matrix size FOV spatial resolution
TWIST 1.4 ms 3.8 ms 15◦ 128 × 128 (128 × 128) mm2 (1 × 1 × 4) mm3
3.2.2 Imaging Protocol
For a better comparability, all measurements were exclusively performed at the
MAGNETOM Skyra scanner with the 15 channel phased array knee coil. To ob-
tain high temporal and spatial resolution, the examination was performed with
the 3D TWIST sequence, parameters are given in Table 3.2. Parallel imaging
was used to achieve a high temporal resolution. Unless otherwise specified, a
PAT = 2 was applied following the clinical protocol specification. Images were
acquired in the transverse plane. Thus, the flow direction within the fibers in-
tercepts the imaging plane. A continuous acquisition over a volume of 6 slices
for 100 seconds with a nominal temporal resolution of 2 s per volume resulted
in a total of 50 volumes. Right after the 5th volume had been acquired, 1 ml of
a Gd based CA (Dotarem or Gadovist) was administered intravenously. It was
followed by a 10 ml saline flush to ensure a coherent bolus during its passage.
Both solutions were injected with a flow velocity of 1 ml/s.
For the evaluation of the measured DCE MRI data, the area of the AIF and the
tissue volume was marked (Figure 3.12). The AIF was determined by placing
a ROI in the tube in front of the phantom inlet. To avoid inflow effects and to
minimize partial volume effects due to the small vessel diameter, a reasonable
large tube was chosen and the ROI was measured in its center. The AIF and
tissue volume was chosen on the same slice in the first third of the phantom
length. OsiriX and its implemented perfusion plugin was used for the evaluation
of perfusion parameters. All data were normalized by subtracting the mean in-
tensity of five baseline volumes and a linear relationship of the CA concentration
to the measured signal intensities was assumed.
3.2.3 Feasibility
It was examined whether the theoretical considerations could be implemented
in practice. For this purpose three experimental setups were performed.
Setup 1: Washout The ability of Gd molecules to cross the semipermeable
membrane was investigated. Thus, 5 ml of diluted CA (1:3) were injected into
the fiber circuit of the phantom before the measurement. The input and output
of the fiber circuit were closed and the phantom was connected to the tubes of
the dialysate circuit. The dynamic DCE MRI measurement with the parameters
described above and the pump for water transport were started simultaneously.
It was observed whether the counter flow was capable of washing out the CA
molecules migrated through the semipermeable membrane from the external
dialysate circuit (Figure 3.13).
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Figure 3.12: Evaluation of the acquisition data of the perfusion phantom. (1) Ac-
quisition starts before CA administration to measure the baseline. (2)
CA is injected and reaches the AIF (3) and shortly after the tissue.
The ROI to determine AIF (orange) and tissue signal (purple) is placed
in the same slice and remains constant for all measurements. Mea-
surement continues until washout phase ends, e.g. the signal reaches
baseline level again.
Signal over time of the acquired washout data was analyzed. For the quan-
tification of the measured data, the clearance was determined analogously to
(Rowland et al., 1973). Its value is expressed by the following differential equa-
tion which can be interpreted as the inverse of the removal rate of a substance
from the body divided by its distribution volume
v
dC
dt = −K · C + m˙. (3.2.1)
Mass change m˙ is given in (mmol/min) or (mol/s), clearance K in (ml/min)
or (m3/s), concentration C in (mmol/l) and volume of distribution v in (l).
Solving this equation results in
C = m˙
K
+
(
C0 − m˙
K
)
e
K·t
v (3.2.2)
with C0 being the concentration in the beginning of the measurement. An
exponential fit was performed on the measured data points to determine the
corresponding parameters.
Setup 2: AIF and tissue measurement The aim was to verify whether
the phantom is capable of producing realistic AIF curves and tissue curves.
Turbulence in the tube or bending or sinking of the CA in the phantom caused
by insufficient pressure or unsuitable phantom size and shape would change
the signal curves. They would no longer show the behavior described in sub-
section 2.4.3. The dialysate circuit was locked for this purpose. Water and
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CA with the settings described above were pumped through the fiber circuit
(Figure 3.13). Four different pumping velocities of v = (12, 14, 16, 20) ml/s
were chosen. The ROIs of AIF and tissue were selected once and kept in the
same way for all velocities. A simplified gamma variate fit according to Chan
and Nelson (2004) was performed
Γ(t) = , t ≤ τ (3.2.3)
Γ(t) = + (Γmax − ) e α(1−
t−τ
tmax−τ )
(
t− τ
tmax − τ
)α
, t > τ. (3.2.4)
 is the baseline of the signal, the curve is starting at time τ , the signal max-
imum is at Γmax, tmax is the time the maximum is reached and α defines the
shape of the function. Start of the CA signal curve, time of maximum as well
as peak height was compared for the AIF and the tissue signal.
Setup 3: Full performance evaluation Both previous approaches were
combined. The aim was to investigate the effects of an additional flow of wa-
ter through the dialysate circuit on the signal generated by the flow through
the fiber circuit. Two settings were investigated. The additional flow was in-
corporated in same- and counter direction to realize fluid exchange in the two
compartments (Figure 3.13).
3.2.4 Reproducibility
The ability of the phantom to provide quantifiable and reproducible perfusion
maps was investigated. With the standard settings described above and in
experimental setup 2, the measurement was repeated five times during one
measurement cycle to determine the inter measurement reproducibility. Based
on the results of the feasibility tests, the pump speed was set to 16 ml/s for the
following experiments. One week later, the same measurement was repeated to
check if the results were reproducible over time. The phantom was positioned
as identically as possible in the knee coil and in the scanner in general. Thus the
same ROI for AIF and tissue as in the measurement one week before could be
used. The 2CX was applied and pixel wise fits were performed. The perfusion
parameters PF, PV and MTT as well as the permeability parameters EF and
PSAP were determined and the fit accuracy was evaluated using AIC and χ2.
Parameter maps were created and the mean values and standard deviations of
the tissue ROIs were calculated.
Setup 3 was adjusted to compare both settings quantitatively. A pixel wise
2CX fit was applied to create perfusion, permeability and fit maps. The calcu-
lated mean and standard deviation was opposed to those obtained with setup
2.
3.2.5 Temporal Resolution and PAT
The influence of different sampling rates on the perfusion parameters and their
fit quality was investigated. The different sampling resolutions Ts were achieved
by varying the PAT factor. Imaging parameters were maintained from previous
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Figure 3.13: Experimental setups for the perfusion phantom study. The red arrows
and dialyzer entrance indicate the flow circuit through the fibers, the
blue ones the flow circuit through the dialysate circuit. Slabs in green
show the measured slice of AIF and tissue.
Setup 1: Measurement of the washout curve to investigate the ability
of gadolinium molecules to cross the semipermeable dialyzer mem-
brane.
Setup 2a: Measurement of an artificial AIF.
Setup 2b: Measurement of an artificial tissue function.
Setup 3: Measurement of the artificial tissue function with an addi-
tional flow through the dialysate circuit in flow and counterflow direc-
tion.
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experiments and can therefore be found in Table 3.2. The total measurement
time for each measurement was 1 minute, whereby the different temporal reso-
lutions Ts = (3.8, 2.7, 2.3, 2.1, 2.0, 1.9) s were achieved. These corresponded
to parallel imaging factors PAT = (1, 2, 3, 4, 5, 6). The inter- and intra-
measurement precision of the PF depending on the sampling resolution was
investigated.
1: Intra measurement precision To investigate the homogeneity within
a single measurement, the intra measurement precision was determined by the
standard deviation σintra of the PF in each ROI of the pixel wise fit such as the
mean fit quality χ2intra .
2: Inter measurement precision Measurements were repeated five times
for each PAT setting to determine the inter measurement precision by the stan-
dard deviation of the mean values PFinter ± σinter among each other.
Statistical analysis was performed for all above-mentioned quantities with an
unpaired t-test (P < 0.05) in Matlab.
3.2.6 Application for ASL
The feasibility of the phantom for perfusion measurements using ASL and a
comparison to the results obtained with DCE measurements was evaluated.
For this purpose, ASL measurements were performed in the same measure-
ment session and with the same experimental settings as the conventional DCE
measurements. The selected experimental design offers the advantage that the
complete experimental setup needs hardly any modifications. The access for
the CA is no longer required and plugged off. An AIF no longer needs to be
measured. Since the tube does not affect the image quality, the setup is not
changed in order to ensure same setup alignment for comparability.
A PASL sequence was used with parameters given in Table 3.3. It creates
a perfusion-weighted image from the signal difference between control and la-
bel acquisition. This perfusion-weighted image data was used to calculate a PF
map pixel by pixel applying the following formula (Alsop et al., 2015)
PF = λ2α · TIF ·
∆M(TIF)
M0
· exp
(
TIF
T1
)
(3.2.5)
with the plasma flow PF in ml/100 g/min, the blood-tissue water partition
coefficient λ = 0.9 ml/100 g, the inversion efficiency α = 0.98, the prescan
image M0 and the control-label image ∆M(TIF). The longitudinal relaxation
time of the tissue T1 was set to 4000 ms for water and the inversion time TIF
was set to 2400 ms.
PF was determined by placing a ROI in the calculated map. Results regard-
ing mean value and standard deviation were compared to those of the DCE
measurements.
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Table 3.3: Imaging parameters of the quantitative ASL MRI phantom study.
Sequence TE TR FA matrix size FOV spatial resolution
PASL 37.96 ms 7000 ms 180◦ 128 × 64 (288 × 144) mm2 (2.25 × 2.25 × 5) mm3
3.2.7 Application for DCE CT
The material properties of the phantom make CT measurements feasible. An
important difference to consider here is the applied CA. The Gd containing MR
CA was replaced by the iodine containing CA used in CT. Physiologically, this
molecule also is able to penetrate the artificial endothelial wall. The size of the
semipermeable membrane of the phantom capillaries permit a transfer in theory.
To verify these assumptions, setup 1 and 2 of the feasibility and reproducibility
measurements with the MR were repeated with the CT scanner.
Setup 1: Washout First, it was examined whether iodine molecules can
cross the semipermeable membrane. Thus, 5 ml of diluted CA (1:3) of the CA
were injected into the fiber circuit of the phantom before the measurement. The
setup was identical with the one described in Figure 3.13. The corresponding
acquisition parameters are given in Table 3.4. The measurement took 40 s with
a measurement every second, resulting in a dose of about 100 mGy. Longer
measurement times were not possible due to the restrictions of the scanner, thus
this setting differs in comparison to the MR measurements. Signal evaluation
of the acquired washout data was analyzed and compared quantitatively to the
results of the MR measurement. Therefore the exponential fit was performed
analogue to the MR measurement to obtain parameters such as clearance.
Setup 2: AIF and tissue measurement It was reviewed whether the
phantom is capable of producing realistic AIF and tissue curves for CT mea-
surements. Therefore the experimental setups as described in Figure 3.13 were
used in the CT scanner. Three different pumping velocities with v = (16, 18,
20) ml/s were chosen. A gamma variate fit to investigate start of the CA signal
curve, time of maximum as well as peak height for the AIF and the tissue signal
was performed according to Equation 3.2.4. This experiment was especially
crucial as the iodine containing CA has a higher viscosity than the Gd con-
taining one. A sticking or clogging should therefore be excluded. Quantitative
perfusion maps of PF, PV and MTT using the FD method were produced. CM
could not be applied since the evaluation is not yet possible with the Osirix
plugin. Mean values and standard deviations were calculated and compared
with the MR results.
Table 3.4: Imaging parameters of the quantitative DCE CT phantom study.
Sequence tube voltage tube current matrix size FOV spatial resolution
standard abdomen 70 kV 150 mAs 512 × 512 (1024 × 1024) mm2 (2 × 2 × 2) mm3
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3.3 DCE in Vivo Study in Rectal Cancer
Patients
Perfusion measurements of patients with rectal carcinoma were evaluated using
the DCE technique. They were acquired in clinical routine as qualitative pre-
treatment scans. In this study they are quantitatively evaluated in the context
of future improvements of the measurement workflow and to extend the scope
of applications.
3.3.1 Patients
The prospective single-center study was approved by the Institutional Review
Board (Medizinische Ethikkommission II, Medical Faculty Mannheim, Heidel-
berg University, Germany) and written, informed consent of all patients was
obtained. All analyses were carried out in accordance with the ethics board ap-
proval. 26 patients with newly-diagnosed untreated rectal cancer were enrolled
within a period of 2 years (December 2013 to December 2015) and underwent
MRI of the pelvis including perfusion sequences covering their tumor. Eight
patients had to be excluded from the study due to poor image quality. This
resulted in final evaluation of 13 male and 5 female patients with a mean age of
64 ± 10 years. The tumor grade was staged T2 (4 patients), T3 (13 patients)
or T4 (1 patient).
3.3.2 Data Acquisition
Acquisition Parameters
DCE MRI data was acquired with a 3T scanner either MAGNETOM Skyra
or MAGNETOM Tim Trio depending on the availability of the device in clinical
routine and without further specific indication. A standard spine coil and body
coil were used. To obtain high temporal and spatial resolution, the examina-
tion was performed with a 3D TWIST sequence, according imaging parameters
are given in Table 3.5. Images were either acquired in axial plane or tilted in
direction of the coronal plane to cover the tumor best as possible. A continu-
ous acquisition over a volume of 20 slices for 5 minutes and 50 seconds with a
nominal temporal resolution of 5 s per volume resulted in a total of 70 volumes.
Right after the 10th volume had been acquired, 3 - 18 ml (0.1 to 0.15 ml per
kg body weight) of Gd based CA Dotarem or Gadovist were administered in-
travenously and followed by a 40 ml saline flush. Both solutions were injected
with a flow velocity of 1.5 ml/s.
Table 3.5: Imaging parameters of the quantitative DCE MRI in vivo study in rectal
cancer patients
Sequence TE TR FA matrix size FOV spatial resolution
TWIST 1.44 ms 3.6 ms 15◦ 192 × 144 (260 × 158) mm2 (1.4 × 1.1 × 3.5) mm3
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Signal Analysis
Both the healthy rectal wall and the tumor are supplied by several arteries.
The aorta abdominalis, which originates from the center of the body, branches
out symmetrically to the left and right side of the abdomen into several smaller
vessels. The rectal wall is therefore supplied by many individual arteries with
different points of attachment. During evaluation of measured DCE MRI data,
the area for AIF determination and the tumor volume was initially marked in
a anatomical T2-weighted image with high spatial resolution for a precise se-
lection. The result was then transferred to the T1-weighted TWIST image
(Figure 3.15). The AIF was determined by carefully placing a ROI in the arte-
ria iliaca externa (Figure 3.14) to avoid inflow effects and to minimize partial
volume effects due to the small vessel diameter. It was determined by a region
growing algorithm with manually set thresholds. Analysis of DCE MRI data
was performed for all patients were a ROI could be placed in the left as well
as the right side iliac artery and produced an AIF. The tumor volume was cho-
sen on the slice with the largest tumor intersection and the whole volume was
outlined under supervision of a radiologist with three years of experience in ab-
dominal imaging using OsiriX and the implemented perfusion plugin. All data
were normalized by subtracting the mean intensity of five baseline volumes and
a linear relationship of the CA concentration to the measured signal intensities
was assumed.
3.3.3 Bilateral Blood Supply and AIF Selection
The discrepancy of quantitative perfusion parameters dependent on the chosen
artery used as AIF was investigated.
The selection of the ROIs is shown for a representative patient in Figure 3.15.
The signal over time of left and right AIF was compared for every patient quali-
tatively. Quantitative analysis of the DCE MRI image data was performed using
the three above mentioned approaches: a voxel-by-voxel FD approach, a model
based 2CU and a model based 2CX. PF, PV and MTT were calculated using
left and right side AIF as well as the permeability parameters PSAP and EF.
The fit quality of the parameters dependent om AIF selection was compared
afterwards. As an alternative to selecting one AIF, a combination of both AIFs
for a better representation of the actually arriving blood and CA bolus was
investigated. Subsequently, the mean of the combined areas of both arteries
was determined. For this purpose, the average of all pixel values in the two
ROIs was calculated by AIFnew = mean(AIFleft
⋃AIFright). This new AIF was
then used to recalculate the parameters previously listed.
First, the results of the individual patients were evaluated. Furthermore, the
averaged effects of the entire study group were analyzed applying a box plot.
For a statistical analysis a paired t-test was performed to determine if there was
a significant difference between one-sided calculation of AIF and averaged AIF
utilization. The significance level was set to P < 0.05.
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Figure 3.14: Anterior view of the anatomical structure of the rectum with the main
feeding arteries. Blood supply is branched symmetrically to the left
and right side of the abdomen into several smaller vessels (Sabiston
et al., 2001).
Figure 3.15: MR image of the abdomen of a representative patient with rectal tu-
mor. (a) ROI for AIF and tumor were identified on the slices with
their best representation. The AIF (green) was determined by a region
growing algorithm with manually set thresholds. The tumor ROI (red)
was manually outlined. ROI selection was performed in consensus with
a radiologist. (b) Healthy rectum wall outlined as reference performed
in consensus with a radiologist.
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3.3.4 Compartment Models and Model Free Approach
Different pharmacokinetic models for quantitative DCE analysis were investi-
gated. As a reference, the voxel-by-voxel FD approach mostly used in daily
clinical practice for T1-weighted DCE MRI was used. The model based 2CU
and a model based 2CX were compared to those results.
To account for both supplying arteries, the combined signal of the AIF ROIs
was used to calculate an averaged AIF over all voxels based on the results of
subsection 3.3.3. All other settings and ROIs were maintained from the above
study to calculate perfusion parameters PF, PV and MTT and permeability
parameters PSAP and EF. The AIC and χ2 were obtained to estimate the
goodness of the fit.
To obtain a tissue comparison, a ROI was placed in healthy rectum tissue
of 10 patients and mean perfusion parameters were obtained (Figure 3.15).
The rectal wall is generally rather thin. In addition, acquired slices are those
containing the tumor in which the healthy wall has receded even further. The
number of evaluable pixels was very small in some patients and not representa-
tive. Therefore, this comparative measurement could not be carried out in the
entire patient cohort. The evaluation was performed analogous to the evalua-
tion of the tumor tissue described above.
A statistical analysis of the data was performed. Bland Altman plots were
generated to analyze perfusion parameters for every single patient for all possi-
ble pairs of two different models, respectively. Lilliefors test was conducted to
test for normal distribution within the three groups. Since not all data was nor-
mally distributed, nonparametric paired Wilcoxon sign rank test was employed
for further analysis of the quantitative perfusion values within different models.
The average values in each of the ROIs were compared for this test. A signif-
icance level of P < 0.05 was set. The severeness of the tumor of the patient
cohort was divided into tumor stages. The mean values of the perfusion pa-
rameters were additionally determined separately according to this classification
and compared with the total mean.
3.3.5 2D and 3D Evaluation
The influence of quantitative 3D volume DCE MRI in rectal cancer on perfusion
parameters was investigated and compared to the data obtained by selecting a
single 2D tumor slice.
Due to artifacts or insufficient coverage of the tumor on several slices, this
investigation was conducted only on five patients (5 male, 64 ± 5 years) whose
tumor was well recognizable on several slides. The settings and AIF ROIs were
maintained from the above study.
The tumor tissue ROI was selected within the tumor volume by a performing
physician according to the standard clinical procedure of analyzing DCE MRI
data using only one slide. In the same way as in daily clinical practice, the choice
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Figure 3.16: Three dimensional representation of the tumor volume consisting of
five subsequent slices of signal data acquired with TWIST of a repre-
sentative patient.
of one particular slice depended on the performing physician. Hereinafter, four
additional ROIs were drawn on slices around the selected central tumor slice
to delineate the entire tumor volume (Figure 3.16). Perfusion parameters (PF,
PV, MTT) in the tumor were calculated pixel wise for each individual slice sep-
arately using the 2CU. The mean values of areas of the slices within the volume
were calculated and the relative deviation of the smallest to the largest area as
well as from the single slice chosen initially by the physician to the mean was
calculated.
3.3.6 Comparison DCE CT
In order to obtain more tissue information, an additional perfusion CT scan was
performed on the patients in this study. Volume perfusion CT was acquired on
the Somatom Force CT system. The tube voltage varied between 80, 90 or
100 kVp and a tube current of 220, 150 or 100 mAs respectively, depending
on the patient’s body weight. The slice thickness was 1.5 mm. 50 ml of the
intravenous CA Imeron with an iodine concentration of 400 mg iodine/ml were
automatically applied with a following 50 ml saline flush. The scan was started
5 s after the start of CA injection. The temporal resolution was 1.5 s and a
total of 19 scans were taken. After the measurement, an algorithm for noise
reduction and an algorithm for motion correction (Siemens syngo.via CT Body
Perfusion VA30, Siemens Healthineers, Erlangen, Germany) were automatically
performed. It was attempted to find a comparable slice to the MR evaluation
and to select AIF and tumor ROI similarly (Figure 3.17). Since the evaluation
with CM for CT data is not yet possible with the Osirix plugin used here, the
perfusion values could only be determined with the FD approach. PF, PV and
MTT were estimated in tumor tissue and normal rectal wall and were compared
with the determined MR values.
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Figure 3.17: CT image of the abdomen of a representative patient with rectal tu-
mor. (a) AIF and tumor were identified on the slices with their best
representation. The AIF (orange) was determined by a region growing
algorithm with manually set thresholds. The tumor ROI (purple) was
manually outlined. ROI selection was performed in consensus with a
radiologist.
Results4
The results of this thesis are given in this chapter. Following the order of the last
chapter, results of general calibration is given first. Afterwards the investigation
of the designed perfusion phantom on feasibility and reproducibility in DCE MRI
and application for other imaging techniques is given. The last part deals with
the results of the DCE MRI in vivo study on rectal cancer patients of which
parts have been published in (Gaa et al., 2017).
4.1 Contrast Agent Calibration
MR CA Calibration
For calibration, the signal intensities of the successively measured samples were
plotted against their concentration (Figure 4.1). The diagram shows a steep
increase, followed by a plateau region and a subsequent decrease of the signal
with an increase of concentrations. A linear relationship between concentration
and signal can thus not be assumed in principle. Zooming to smaller concen-
trations up to 2 mmol/l, an approximately linear course can be observed. This
behavior corresponds to that described in the literature (Shahbazi-Gahrouei
et al., 2001) for Gd containing CA in MR. Since the linear range covers the CA
concentrations commonly used in clinical routine, no further correction meth-
ods were used and a linear characteristic was assumed in the following.
CT CA Calibration
The signal intensities of iodine containing CA probes was plotted against their
concentration (Figure 4.2). The measured data points follow a linear slope.
This is in accordance with Hansen et al. (2014), who additionally showed that
higher tube voltages lead to a steeper slope, however, they should be avoided
as they result in a higher patient dose. Due to the linear relationship for the
measured clinically used CA concentrations further correction methods were not
applied.
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Figure 4.1: Calibration of the relationship between the concentration of the Gd
containing CA Dotarem and the measured signal in MRI using a CA
phantom.
Figure 4.2: Calibration of the relationship between the concentration of the iodine
containing CA Imeron and the measured signal in CT using a CA phan-
tom.
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Figure 4.3: Experimental setup 1: Washout. A signal decrease is caused by CA
transfer through the semipermeable membrane from fibers to dialysate
space and subsequent washout. The data points follow a typical clear-
ance function.
4.2 DCE Perfusion Phantom Study
4.2.1 Phantom design
The calibration of the peristaltic pump was performed, feasible velocities be-
tween 12 ml/s and 20 ml/s were found. These correspond to the order of
magnitude of blood flow velocities in the human body in larger arteries. At
lower speeds, the pressure of the pump is not sufficient to overcome the differ-
ences in height in the measuring setup and air bubbles are created in the tube.
At higher speeds, the vibrations of the pump are transferred to the tube to such
an extent that movement artifacts are introduced during AIF and tissue signal
measurement (Figure 4.4).
4.2.2 Feasibility
Setup 1: Washout The CA stored in the fiber circuit in the phantom causes
a high signal intensity in the measured T1-weighted MR signal at t = 0 s. The
subsequent washout by the water flow through the dialysate circuit is expressed
in a decreasing signal (Figure 4.3). The measured signal data points follow a
typical clearance function. The performed fit revealed a clearance of K = 207
ml/min according to the formula described in Equation 3.2.2.
Setup 2: AIF and tissue measurement Evaluation of the measured sig-
nal could demonstrate that the phantom generates artificial AIFs and tissue
functions with characteristic first pass - the steep increase in the signal - and
typical washout slopes for all tested flow velocities (Figure 4.4). Results of the
gamma variate fit are given in Table 4.1. The start time τ of the AIF signal
curve is consistent for all four velocities. The height of the maximum Γmax
increases with higher velocities and the time of the maximum tmax is reached
slightly earlier for higher velocities. In the tissue, the start time τ is delayed for
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Table 4.1: Results of the gamma variate fit used for AIF and tissue data points for
different flow velocities. The start time τ , the height of the maximum
Γmax and the time of the maximum tmax are given.
flow velocity 12 ml/s 14 ml/s 16 ml/s 20 ml/s
AIF
τ (s) 17 17 17 18
Γmax 634 783 915 1090
tmax (s) 21 21 20 20
tissue
τ (s) 25 24 22 21
Γmax 66 62 60 59
tmax (s) 33 32 29 26
lower velocities. The height of the maximum Γmax increases slightly with lower
velocities and the time of the maximum tmax is reached earlier for higher veloc-
ities. The tissue signal intensities are reduced and the curve width is broadened
compared to the AIF signal.
Setup 3: Full performance evaluation Identical effects on the tissue
function for additional flow in the dialysate circuit both in same direction and
counter direction to the flow in the fibers were revealed. The additional flow
leads to a reduced overall signal, it decreased from 55 a.u. to 28 a.u. for both
flow directions. A reduced slope in the wash in phase and a faster decay was
measured and is depicted in Figure 4.5.
4.2.3 Reproducibility
In Figure 4.7, the pixel wise calculated parameter maps and in Table 4.2 the
corresponding mean values with standard deviation in the tissue ROI of the
five subsequent reproducibility measurements for the perfusion parameters PF,
MTT and PV are given. Additional information about the extravasation of
the CA into the dialysate circuit could be obtained by fitting the 2CX. Mean
values with standard deviation of PSAP and EF have been calculated. The fit
quality was determined with AIC and χ2. A representative fit using the 2CX is
depicted in Figure 4.6. The five measurements were averaged, the percentage
standard deviation of the mean are 8 % for PF, 6 % for PV, 13 % for MTT.
The deviation of the PSAP was highest with 18 % and the standard deviation
of EF was 12 %. Values are given in Table 4.3.
Here, also the results of all parameters for the second measurement after one
week are depicted and can be compared to the mean and standard deviation
of the five measurements the week before. PF stays constant compared to the
mean of the five measurements at t = 0. All other values show a decrease of
∆PV = 22 %, ∆MTT = 10 %, ∆PSAP = 5 % and EF ∆EF = 10 %. The
AIC is slightly decreased by less than 5 %, χ2 is within the results of the earlier
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Figure 4.4: (a) Plot of the MR signal in the phantom’s artificial artery over time for
four different flow velocities resulting in AIFs and (b) signal in the phan-
tom’s artificial tissue region over time for four different flow velocities
resulting in typical tissue functions. A delay and broader distribution
can be observed for lower velocities.
measurement. All measured values lie within the standard deviation.
When the experiment was switched to setup 3, the calculated perfusion values
with additional flow in same/counter direction showed a decrease of (36/43)
% for PF and (52/26) % for PV. MTT remains constant. PSAP decreases
by (67/76) % and EF by (17/26) %. The AIC decreases by (57/50)%, χ2 is
higher for flow in same direction and reduced for flow in counter direction by
(16/33) % (Table 4.3).
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Figure 4.5: Plot of experimental setup 2: The tissue signal in blue caused by flow
through the fiber circuit and plot of experimental setup 3: Changed
tissue signal due to additional flow in the dialysate circuit in same and
counter direction of the fiber circuit. The additional flow leads to a
reduced overall signal and a faster decay.
Figure 4.6: Phantom tissue signal produced with setup 2 and fit curve obtained
with the 2CX.
Table 4.2: Mean ± standard deviation of pixel wise calculated results for PF, PV,
MTT, PSAP, EF, AIC and χ2 using the 2CX. The results were obtained
in a single measurement session. The five subsequent measurements
were performed without modification in the setup.
1 2 3 4 5
PF (ml/100 ml/min) 104 ± 34 91 ± 29 89 ± 27 87 ± 26 85 ± 19
PV (ml/100 ml) 73 ± 30 61 ± 22 68 ± 28 68 ± 28 72 ± 29
MTT (s) 28 ± 12 27 ± 8 28 ± 10 34 ± 13 30 ± 9
PSAP (ml/100 ml/min) 51 ± 35 34 ± 30 32 ± 24 36 ± 30 42 ± 26
EF (%) 29 ± 12 21 ± 16 25 ± 17 25 ± 18 28 ± 18
AIC 302 ± 16 307 ± 15 310 ± 15 312 ± 16 315 ± 15
χ2 6 ± 2 4 ± 2 6 ± 1 6 ± 2 7 ± 2
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Figure 4.7: Pixel wise fitted maps in the artificial tissue by applying the 2CX. Perfu-
sion parameters PF, PV, MTT in the first row, permeability parameters
PSAP and EF in the second row and χ2 and AIC to determine the
goodness of fit in the third row.
Table 4.3: Mean ± standard deviation of pixel wise calculated results for PF, PV,
MTT, PSAP, EF, AIC and χ2 using the 2CX. The left side shows the
mean of the five subsequent measurements ± standard deviation of the
mean in the first week at t = 0. The right side shows mean ± standard
deviation one measurement after 1 week.
t = 0 t = 1 week
PF (ml/100 ml/min) 91 ± 7 91 ± 26
PV (ml/100 ml) 68 ± 4 53 ± 23
MTT (s) 29 ± 4 26 ± 11
PSAP (ml/100 ml/min) 39 ± 7 37 ± 26
EF (%) 26 ± 3 23 ± 19
AIC 309 ± 4 299 ± 16
χ2 6 ± 1 6 ± 2
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Table 4.4: Mean ± standard deviation of pixel wise calculated results using the 2CX
for PF, PV, MTT, PSAP, EF, AIC and χ2 achieved with additional flow
in the dialysate circuit in same and in counter direction.
additional flow
in same direction
additional flow
in counter direction
PF (ml/100 ml/min) 58 ± 22 51 ± 20
PV (ml/100 ml) 25 ± 16 39 ± 23
MTT (s) 25 ± 13 26 ± 19
PSAP (ml/100 ml/min) 12 ± 9 9 ± 8
EF (%) 19 ± 17 17 ± 12
AIC 127 ± 10 149 ± 13
χ2 7 ± 3 4 ± 2
Table 4.5: Mean values ± standard deviations for σintra, χ2intra and PFinter depen-
dent on PAT and sampling rate.
PAT / Ts(s) 1 / 3.8 2 / 2.7 3 / 2.3 4 / 2.1 5 / 2.0 6 / 1.9
σintra
(ml/100 ml/min) 25.8 ± 0.7 26.4 ± 1.2 26.8 ± 1.3 24.2 ± 4.7 20.4 ± 1.5 19.8 ± 1.6
χ2intra 6.4 ± 0.2 5.7 ± 0.1 5.1 ± 0.1 5.1 ± 0.2 5.4 ± 0.1 5.4 ± 0.1
PFinter ± σinter
(ml/100 ml/min) 77.0 ± 2.7 78.2 ± 4.1 75.0 ± 4.9 83.4 ± 8.2 84.0 ± 4.4 80.2 ± 4.3
4.2.4 Temporal Resolution and PAT
The AIF and pixel wise calculated maps for PF for different temporal resolutions
by variation of the PAT factor are shown in Figure 4.8. Corresponding mean
values and standard deviation are given in Table 4.5.
Moreover, a quantitative analysis was carried out.
(1) Intra measurement variability: For each individual measurement, σintra of
the PF within the phantom and the fit quality χ2intra are depicted in the boxplot
in Figure 4.9 to determine the robustness and performance of the fit. The sta-
tistical evaluation showed that σintra of the PF is significantly smaller for PAT
= 5 and PAT = 6 compared to the other measurements. For χ2intra the values
for PAT = 1 are significantly higher.
(2) Inter measurement variability: The median and interquartile range of the
mean values of PFinter within the measurement series are shown in the boxplot
in Figure 4.9. The unpaired t-test reveals a significant lower value for PAT =
1 and PAT = 3 measurements compared to PAT = 5, an elevated median is
noticeable here in the boxplot.
4.2.5 Application for ASL
The control and label images generated with the ASL sequence in an intermedi-
ate step provide homogeneous results of the phantom flushed with water. They
are depicted in Figure 4.10 together with the perfusion-weighted image calcu-
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Figure 4.8: Pixel wise calculated PF maps for different temporal resolutions Ts
achieved by parallel imaging (PAT). Sampling rate of the last mea-
surement is twice as high compared to the first one.
lated from these scans. PF was determined pixel wise in a ROI in the artificial
dialyzer tissue. The mean values of this measurement with PF = (98 ± 36)
ml/100 ml/min agree well with the subsequently performed DCE measurement
PF = (91 ± 26) ml/100 ml/min. The standard deviation is increased by 44 %
for the ASL measurement compared to the DCE measurement.
4.2.6 Application for DCE CT
The measured CT signal obtained with experimental setup 1 shows a high HU
signal caused by the CA locked in the fiber circuit in the phantom at t = 0 s.
The subsequent washout by the water flow through the dialysate circuit is ex-
pressed in a decreasing signal in Figure 4.11. The measured signal data points
follow a typical clearance function as described in Equation 3.2.2, the performed
fit revealed a clearance of K = 203 ml/min. This is in good agreement with
the result of the MRI measurement of K = 207 ml/min.
Evaluation of the signal of experimental setup 2 shows that the phantom gener-
ates AIFs and tissue functions with characteristic first pass - the steep increase
in the signal - and typical washout slopes for all tested flow velocities (Fig-
ure 4.12). Results of the gamma variate fit are given in Table 4.6. The start
time τ of the AIF signal curve is delayed for lower velocities, the height of the
maximum Γmax increases with higher velocities. The time of the maximum tmax
is reached earlier for higher velocities. The start time τ of the tissue signal
curve is delayed for lower velocities and the height of the maximum Γmax is
decreased for the highest velocity due to a higher baseline signal. The time
of the maximum tmax is reached earlier for higher velocities. The intensities
of the tissue signal are reduced and the curve width is broadened compared to
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Figure 4.9: Intra measurement variability: (a) Boxplot for σintra and (b) χ2intra .
Inter measurement variability: (c) Boxplot of PFinter . Each plot shows
PAT = (1, 2, 3, 4, 5, 6) with corresponding Ts = (3.8, 2.7, 2.3, 2.1,
2.0, 1.9) s. The median is depicted by a red line, first and third quartile
are shown in blue, whiskers at 1.5 times the interquartile distance in
black.
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Figure 4.10: Phantom measurement using DCE MRI and ASL. DCE operating steps
on the left side: AIF and tissue function are used for tracer kinetic
modeling. ASL operating steps on the right side: Control and label
image in the artificial tissue of the phantom are measured and perfusion
weighted image is subsequently calculated by the scanner software. PF
map was calculated pixel wise.
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Figure 4.11: Plot of the signal decrease caused by CA transfer through a semiperme-
able membrane from fibers to dialysate space and subsequent washout.
The data points follow a typical clearance function.
Table 4.6: Results of the gamma variate fit used for AIF and tissue data points for
different flow velocities in DCE CT. The start time τ , the height of the
maximum Γmax and the time of the maximum tmax are given.
flow velocity 16 ml/s 18 ml/s 20 ml/s
AIF
τ (s) 25 23 19
Γmax 282 337 339
tmax (s) 27 25 21
tissue
τ (s) 32 29 27
Γmax 46 46 43
tmax (s) 36 31 29
the AIF measurements. A comparison of the curve progression of the MR and
CT measurement shows differences in the start time of the AIF signal curves,
MR ones are independent of the flow velocity whereas they start later for lower
velocities in CT. However, the remaining characteristics of the AIF curves are
the same in both modalities. The tissue curves show a delayed behavior at
lower speeds in both modalities. The widening of the bolus is more prominent
in the MR measurements than in the CT measurements.
PF = (94 ± 53) ml/100 ml/min was calculated applying the FD approach
to the CT data, the map is given in Figure 4.13. PV = (21 ± 16) ml/100 ml
and MTT = (22 ± 14) s was furthermore determined.
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Figure 4.12: (a) Plot of the CT signal in the phantoms artificial artery over time
for three different flow velocities resulting in AIFs and (b) signal in
the phantoms artificial tissue region over time for three different flow
velocities resulting in typical tissue functions. A delay and broader
distribution can be observed for lower velocities.
Figure 4.13: Perfusion phantom application in the CT. (a) Native measurement of
phantom and artificial AIF and (b) pixel wise calculated map of PF.
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4.3 DCE in vivo Study in Rectal Cancer
Patients
The results of a retrospective rectal cancer study of 18 patients is presented in
the following. DCE imaging of the tumor tissue with quantitative evaluation
comparing CMs to FD was published in (Gaa et al., 2017). Influence of AIF ap-
plication and tumor selection as well as comparison to CT results is additionally
presented.
4.3.1 Bilateral Blood Supply and AIF Selection
The delineated tumor and the rectangular shaped box for pixel wise calculation
of parameter maps are depicted in Figure 4.14, together with the ROIs for the
AIF placed in the left and right iliac artery. Beside, their corresponding signal
curves of one representative patient are shown.
The total blood supply of the arteries to the tumor and thus the signal over time
differs for left and right AIF especially at the bolus peak. Perfusion parameters
PF, PV, MTT and permeability parameters PSAP and EF determined with the
individual AIF are given in Table 4.7 together with the fit quality calculated us-
ing AIC and χ2. The table shows the results separately for the use of the three
evaluation methods FD, 2CU and 2CX. Summarized results for all patients are
depicted in the boxplots in Figure 4.16 and Figure 4.17. Parameter maps of a
representative patient are shown in Figure 4.15.
The mean values of each single parameter compared for left and right AIF
all lie within the 1σ confidence interval. The maximum deviation is 22 % for
the PF in the 2CX and also in general PF is the parameter with the largest de-
viations. Mean and median show a good agreement, although there are larger
deviations in PSAP and χ2. It is prominent that outliers exist for almost all
parameters and models.
Statistical analysis with a paired t-test revealed significant deviations for the
PF for the use of left and right AIF when the compartment models are used
(2CU: P = 0.04, 2CX: P = 0.04). Furthermore, the EF shows a statistically
significant deviation with the 2CU (P = 0.03). All other parameters show no
significant deviations for the two different AIFs.
The individual patient results using left and right AIF subtracted from each
other are visualized in the boxplot in Figure 4.18. There are considerable devi-
ations, especially in the PF with up to 30 ml/100 ml/min. PF obtained fitting
the CM deviates significantly from zero, meaning values of the right AIF are
significantly higher in the individual patient than for the left AIF. The mean
and median of all parameters show no significant deviation except for PF using
the 2CM. Here, the median is around zero, however the mean is systematically
negative.
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Figure 4.14: (a) Native MR image with ROIs for left (purple) and right (orange) AIF
positioned in the external iliac artery. The tumor of the representative
patient is delineated in blue surrounded by the rectangular shaped box
used for the subsequent parameter maps. (b) Averaged signal in the
AIFs. Differences especially at the bolus peak are clearly visible.
Table 4.7: Mean ± standard deviation of perfusion parameters for left and right
AIF applying FD, 2CX and 2CU.
FD 2CX 2CU
AIFleft AIFright AIFleft AIFright AIFleft AIFright
PF (ml/100 ml/min) 37 ± 21 36 ± 19 61 ± 38 79 ± 61 50 ± 33 64 ± 44
PV (ml/100 ml) 32 ± 18 31 ± 15 16 ± 9 18 ± 12 21 ± 11 22 ± 13
MTT (s) 58 ± 15 58 ± 17 17 ± 9 15 ± 11 28 ± 15 25 ± 15
PSAP (ml/100 ml/min) - - 8 ± 7 9 ± 8 2 ± 2 2 ± 2
EF (%) - - 11 ± 7 9 ± 6 5 ± 4 4 ± 3
AIC - - 165 ± 82 174 ± 85 180 ± 75 184 ± 80
χ2 - - 9 ± 11 11 ± 14 8 ± 9 10 ± 12
76 CHAPTER 4. RESULTS
Figure 4.15: Parameter maps of PF, PV, MTT, PSAP and EF generated with the
2CU in one representative patient using left and right AIF. The tumor
is delineated in blue.
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Figure 4.16: Boxplots visualizing PF, PV and MTT for FD, 2CU and 2CX. The
values are calculated for the left, right and new combined AIF. The
median is depicted by a red line and the mean values by a green dot.
First and third quartile are shown in blue, whiskers at 1.5 times the
interquartile distance in black.
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Figure 4.17: Boxplots visualizing PSAP, EF, AIC and χ2 for 2CU and 2CX. The
values are calculated for the left, right and new combined AIF. The
median is depicted by a red line and the mean values by a green dot.
First and third quartile are shown in blue, whiskers at 1.5 times the
interquartile distance in black.
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Figure 4.18: Boxplots visualizing the differences of PFl-r, PVl-r, MTTl-r, PSAPl-r
and EFl-r for all patients for left and right AIF using the FD, 2CX and
2CU. The median is depicted by a red line and the mean values by a
green dot. First and third quartile are shown in blue, whiskers at 1.5
times the interquartile distance in black.
4.3.2 Compartment Models and Model Free Approach
Figure 4.19 depicts the tissue signal and fit curves for the 2CU and 2CX model
and the tumor signal of one representative patient. Maps of PF, PV and MTT
for one representative patient are shown for the 2CU and 2CX model and the
FD approach in Figure 4.20.
Mean values and standard deviations for estimated perfusion parameters PF,
PV, MTT, the permeability parameters PSAP, EF and fit quality determined
with AIC and χ2 averaged over all 18 patients are given in Table 4.8.
Both the 2CU and the 2CX show similar results for the mean values and all
lie within the 1σ confidence interval. However, slight differences in the fit lead
to higher values for PF (19 %) for the 2CX whereas the mean values for the
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2CU are higher for PV (18 %) and MTT (36 %). The FD results show large
deviations to those calculated with the 2CM with the MTT being three times as
high for the FD compared to the 2CX. Compared to the compartment models
(2CX/2CU), an underestimation of the PF (47 %/35 %) and an overestima-
tion of MTT (72 %/57 %) and PV (41 %/29 %) can be observed for the FD
approach.
This is also visualized in the Bland-Altman plots in Figure 4.21. In all plots,
almost all data points are distributed within the band of agreement placed at
± 1.96 standard deviations. A maximum of two outliers outside the band of
agreement can be observed. Differences between two measures and correspond-
ing standard deviations calculated of the FD approach and one of the 2CM are
higher than the comparison of the CMs among each other.
The results separated by different cancer stages T2, T3 and T4 also given
in Table 4.8 all lie within the 1σ confidence interval for the FD approach when
compared to the initial results. Deviations for the FD range between (0 - 33)
%, highest deviations can be found for T4 cancer stage. A higher dependency
on the tumor stage can be found for the CMs, here deviations range between
(10 - 68) % for the 2CX and (12 - 66) % for the 2CU. For both models, val-
ues for MTT lie outside the 1σ confidence interval. Also, deviations are most
prominent for T4, but also T2 cancer stage. The trend for all parameters and
models is the same, for example for T3 all approaches show a higher PF.
Mean perfusion parameters PF, PV, MTT for healthy rectum tissue were all
smaller compared to the tumor tissue for FD and 2CU. For 2CX, PF and PV are
smaller, MTT is constant. The trends of higher PF and smaller PV and MTT
for the CMs compared to the FD already described for tumor tissue remains
consistent also for the healthy tissue.
Permeability parameters show large deviations; the results for both parame-
ters are about 2.5 times higher for the 2CX compared to the 2CU. The large
standard deviation leads to values lying within the 1σ confidence interval. Pa-
rameters of the fit quality were calculated for both compartment models. These
differed by 5 % regarding AIC and 10 % regarding χ2.
For comparison, the results were also included in the boxplots from subsec-
tion 4.3.1 in Figure 4.16 and Figure 4.17. AIFnew shows the result of the new,
combined AIF. The combination of both sides leads to a mitigation of extreme
outliers which are no longer as strongly weighted by the new approach.
Statistical analysis with the non parametric paired Wilcoxon sign rank test
showed significant differences for the comparison of all models. The P-values
were smaller than 0.01 for all compared models and perfusion parameters. Pa-
rameters for fit quality also showed significant differences, however with higher
P values of 0.02 (AIC) and 0.04 (χ2) (Table 4.9).
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Figure 4.19: Signal in the tumor tissue over time in blue and fit curve calculated
with 2CU (red) and 2CX (green).
Figure 4.20: Pixel wise calculated maps for PF, PV and MTT of the tumor region
of one representative patient for the 2CU and 2CX compared to the
FD approach.
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Figure 4.21: Bland-Altman plots of the perfusion parameters PF, PV and MTT
from top row to bottom row comparing the applied approaches FD,
2CU, 2CX among each other from left to right. The mean value of
the difference between two measures over the mean of two measures is
depicted in blue. The band of agreement (placed at ± 1.96 standard
deviations) is depicted in red.
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Table 4.8: Overview of perfusion, permeability and quality of fit parameters stated
in mean ± standard deviation for the 2CX, 2CU and FD. Values for
healthy rectum wall are given in italic. Separate values for the different
cancer stages are listed. Note that permeability parameters can not
be calculated with the FD approach. Quality of fit parameters are not
depicted for the FD approach as values are calculated directly with this
approach and no fit is required.
Parameter 2CX 2CU FD
Mean of tumor tissue (and healthy tissue)
PF (ml/100 ml/min) 68 ± 44 55 ± 36 36 ± 19
37 ± 19 34 ± 16 27 ± 11
PV (ml/100 ml) 18 ± 11 22 ± 12 31 ± 15
11 ± 4 11 ± 5 19 ± 7
MTT (s) 16 ± 9 25 ± 13 58 ± 16
16 ± 5 20 ± 6 46 ± 16
PSAP (ml/100 ml/min) 7 ± 7 2 ± 2 -
EF (%) 10 ± 7 4 ± 3 -
AIC 169 ± 81 179 ± 77 -
χ2 10 ± 12 9 ± 10 -
T2 (3 patients)
PF (ml/100 ml/min) 41 ± 16 33 ± 5 34 ± 12
PV (ml/100 ml) 25 ± 9 31 ± 7 33 ± 6
MTT (s) 25 ± 13 38 ± 11 67 ± 18
T3 (13 patients)
PF (ml/100 ml/min) 76 ± 47 61 ± 38 37 ± 21
PV (ml/100 ml) 16 ± 11 20 ± 12 31 ± 17
MTT (s) 13 ± 6 22 ± 11 55 ± 15
T4 (1 patient)
PF (ml/100 ml/min) 34 33 27
PV (ml/100 ml) 17 17 26
MTT (s) 27 29 59
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Table 4.9: Statistical determination of pairwise test between the applied evaluation
approaches FD, 2CU and 2CX. P-values obtained with Wilcoxon sign
rank test are given for perfusion parameters PF, PV and MTT and for
AIC and χ2. P < 0.05 was considered as significantly different.
FD - 2CX FD - 2CU 2CX - 2CU
P (PF) 0.0012 0.0079 6.13 E-05
P (PV) 3.51 E-04 7.27 E-04 2.44 E-04
P (MTT) 1.96 E-04 2.32 E-04 6.34 E-04
P (AIC) - - 0.02
P (χ2) - - 0.04
4.3.3 2D and 3D Evaluation
The mean tumor size ± standard deviation of the single slices for the subgroup
of five patients was (5 ± 2) cm2, the mean overall tumor volume ± standard
deviation was (7 ± 2) cm3 with a slice thickness of 3.6 mm. Visualization of
perfusion parameters PF, PV and MTT for all slices and all patients are pre-
sented in Figure 4.22. The figure includes values of the single slice delineated
by the performing physician and mean values with standard deviation for the
combined surrounding slices. The corresponding values are given in Table 4.10
and parameter maps of the PF in five slices in a representative patient can be
seen in Figure 4.23.
Data analysis showed that mean values of the single slice deviate up to 12
% for PF, 14 % for PV, and 7 % for MTT. Values for two of the slices chosen
by the performing physician and in total values of 13 slices are lying outside the
1σ confidence interval of the perfusion parameters acquired over the whole vol-
ume. Maximum deviations between two single slices in a tumor volume range
up to 28 % for PF and PV and 36 % for MTT.
4.3.4 Comparison DCE CT
The results of the volume perfusion CT are given in Table 4.11. They show
mean values and standard deviations for PF, PV and MTT determined with
the FD approach. Compared to the calculated MR values in Table 4.8, the PF
shows good agreement with a deviation of 19 % lying within the 1σ confidence
interval. PV and MTT however show more than 10 times higher values in the
MRI results compared to the CT results. Values of the healthy tissue show
the same trends, the PF and PV decreases whereas the MTT stays constant,
however, also here the MRI results are multiple times higher compared to the
CT results.
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Figure 4.22: Graph of the perfusion parameters PF, PV and MTT calculated for
individual 2D slices and 3D volume of rectum tumor tissue. The value
of the chosen slice of the performing physician is marked in yellow, the
additional ones in blue. The mean value ± standard deviation of all
five slices is given in green.
Figure 4.23: PF parameter maps of five subsequent slices of rectum tumor tissue in
a representative patient. PF values are heterogeneous within one slice
and when compared between the five individual slices.
86 CHAPTER 4. RESULTS
Table 4.10: Mean values of pixel wise calculated parameter maps for PF, PV and
MTT for each single slice and calculated mean value ± standard de-
viation for the entire tumor volume. The value for the slice chosen by
the performing physician is given in bold.
patient # slice 1 slice 2 slice 3 slice 4 slice 5 mean ± std
PF (ml/100 ml/min) 1 76 67 65 68 66 69 ± 4
2 46 49 59 58 46 52 ± 6
3 115 108 99 106 111 108 ± 5
4 62 71 64 70 71 68 ± 4
5 88 61 100 84 79 82 ± 13
PV (ml/100 ml) 1 17 20 15 16 17 17 ± 1
2 8 8 9 9 7 8 ± 1
3 56 49 44 43 47 48 ± 5
4 16 16 16 16 20 17 ± 5
5 7 8 10 8 7 8 ± 1
MTT (s) 1 15 18 15 17 16 16 ± 1
2 15 13 12 11 12 13 ± 2
3 10 9 8 10 9 9 ± 1
4 13 13 12 15 14 13 ± 1
5 5 7 7 6 7 7 ± 1
Table 4.11: Mean values ± standard deviation of the perfusion parameters PF,
PV and MTT for the FD approach calculated on DCE CT data and
compared to the DCE MRI data from Table 4.8. The healthy rectum
wall tissue results are given in italic for comparison.
FD (CT) FD (MR)
Mean of tumor tissue (and healthy tissue)
PF (ml/100 ml/min) 43 ± 12 36 ± 19
15 ± 6 27 ± 11
PV (ml/100 ml) 3 ± 1 31 ± 15
1 ± 1 19 ± 7
MTT (s) 5 ± 2 58 ± 16
5 ± 1 40 ± 16
Discussion5
Two approaches were applied to determine feasibility, improvements and limita-
tions in quantitative DCE perfusion MRI. A perfusion phantom setup suitable
for DCE measurements was developed and a retrospective rectum cancer pa-
tient data set was analyzed. This chapter discusses the findings of these two
parts of the thesis, some of which were published in (Gaa et al., 2017).
5.1 DCE Perfusion Phantom Study
Feasibility
First, the question was addressed whether the phantom meets the require-
ments of a model that reflects the physiology in humans with flow through the
capillaries, the surrounding extravascular space and the exchange between these
two compartments.
In experimental setup 1, the ability of Gd molecules to cross the semipermeable
membrane of the phantom was investigated. It revealed that CA molecules
can cross the fiber wall from dialysate space to fiber space. The migration
of the molecules between the two regions and flushing out the CA followed a
typical washout curve with exponential decay. The CA molecules can move
freely between the two compartments without attaching to the membrane or
remaining in the dialysate space. Thus, the semipermeable membrane of the
fibers enables the simulation of two-compartment kinetics and can thus imitate
capillaries and interstitium in the human body.
The aim of experimental setup 2 was to verify whether the phantom is capable
of producing realistic AIF and tissue curves for different default flow velocities.
The obtained parameters of the performed gamma variate fit correspond to the
set flow velocity. The signal in the artificial AIF in the tube in front of the
phantom starts at the same time for all velocities. Since the AIF is measured
shortly after the injection point of the CA, no offset was anticipated due to
the different velocities. For higher velocities the signal maximum increased and
the curve width decreased which can be explained by the increased speed of
the bolus and the resulting faster passage through the measurement slice. In
the artificial tissue within the phantom, the signal has already dropped overall,
as the CA bolus has widened due to the branching of the wide tube into the
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small fiber capillary. This is also evident in the delayed onset of the tissue
curves, starting much later at a slower flow velocity. The slightly increased
maximum signal at lowest flow velocity compared to the higher velocities does
not correspond to this theory. With a slower widened bolus one would have
expected a lower signal. A possible explanation could be discontinuous flow
in the phantom. This is more likely at lower speeds, as the individual pump
impulses of the peristaltic pump characteristic have a greater influence here.
The effect can clearly be seen in form of spikes in the signal. In the following
experiments such low velocities were no longer used. Nevertheless, a low pump
velocity would have been desirable, as this would have been more in line with
the velocities in human arteries. The lowest artifact free velocity of 16 ml/s
was chosen in the following as the signal in AIF and all other tissue curves
showed no apparent turbulence, distortion or congestion while passing through
the experimental setup.
In experimental setup 3, both previous approaches were combined. Additionally
to the flow in the fiber circuit of the dialyzer, water was pumped through the
outer dialysate circuit. The effects of this additional flow on the signal was
investigated, both with the additional flow incorporated in same- and counter
direction. The simultaneous flow through both compartments led to a reduc-
tion of the signal intensity in the artificial tissue by 49%. This expected result
can be explained by the realized fluid and CA exchange between the two com-
partments. The CA extravasated in the dialysate space is washed out by the
additional flow instead of accumulating there when no additional flow is applied.
The flow direction has no influence on the measured signal.
Overall, the findings of the feasibility experiments show that the perfusion phan-
tom can serve as a tissue mimicking device to measure perfusion in MRI.
Reproducibility
Next, the ability of the phantom to provide quantifiable and reproducible perfu-
sion maps was investigated. The measurement was repeated five times during
one measurement cycle and one week later, the same experiment was repeated
to check if the results were reproducible over time.
The averaged five subsequent measurements showed standard deviations of the
mean of 8 % for PF, 6 % for PV, 13 % for MTT. The deviations of the PSAP
was highest with 18 % and the standard deviation of EF was 12 %. The maps
for fit quality show some extreme outlier voxels which may be caused by single
clogged pores in the membrane. They might be responsible for deviations and
could especially influence permeability. Measurement errors occurring only in a
single measurement could also be caused by air bubbles or turbulence of flow.
After one week, the PF showed no changes compared to the mean value ob-
tained the week before. All other parameters show a decrease between 5 and
22 %, yet all lie within their standard deviation. It can therefore be assumed
that no major impairment of the dialyzer material occurred within this week.
However, it should be noted that poor rinsing of the CA can lead to permanent
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deposits and clogging. Since the filter is commercially available, it should be
replaced in such a case.
If an additional flow in the dialyzer circuit is applied, a decrease in PF, PV,
PSAP and EF is observed. This can be explained, as the CA molecules in
the dialyzer compartment are drained now instead of accumulating there. The
MTT remains the same as this parameter depends highly on the phantoms
characteristics and flow velocity of the bolus and shows a lower dependency on
an additional flow. The fit quality calculated with χ2 depends on the chosen
model and the number of fitted parameters which remained the same. Thus,
no change was expected, which could be confirmed in the experiment.
Even with the standardized phantom used in this thesis, a lot of adjustment
parameters for an optimal fit still exist. For example, start or boundary settings,
the sampling rate as well as the pharmacokinetic model representing the under-
lying physiology have to be found. The advantage is, however, that a phantom
can eliminate many other aspects that would otherwise occur in humans. Every
issue can be examined in an isolated experiment. For example, in this setup,
an additional flow could be adjusted which lowered the AIC. This might be an
indication, that with additional flow, the 2CX fits the data better. Influence
of the sampling rate without further interference of artifacts caused by human
physiology was investigated in the following. Artifacts in the phantom itself for
example voxels that are recognizable as outliers are few. They may be caused by
air inclusions or other stationary turbulence or agglutination of the capillaries.
Such pixels could be excluded from the calculation of the average value in the
future.
Temporal Resolution and PAT
The influence of different sampling rates on the perfusion parameters and their
fit quality was investigated. The different sampling resolutions Ts were achieved
by varying the PAT factor. In literature, the impact on the calculated parame-
ters is a controversial question so far. Previous studies see a predominant quality
enhancing effect with faster sampling rates, especially when pharmacokinetic
models are to be applied (Aerts et al., 2011). A change in the parameter values
themselves was also noted. Ginsburg et al. (2016) describe a larger influence
on Ktrans compared to the PV. However, Othman et al. (2016) could not find
any influence of the sampling rate on perfusion parameters at all. In addition,
Li et al. (2012) proposed SNR loss caused from parallel imaging. As a conse-
quence, the application of PAT factors is used with caution in concern of quality
loss in clinical practice.
Experiments with the perfusion phantom in this thesis found a significant in-
fluence of the PAT factors and Ts on the PF and inter and intra measurement
variability. Significantly smaller intra measurement variability σintra was detected
for the PF using high acceleration factors PAT = 5 and PAT = 6 and for χ2intra
the values for PAT = 1 are significantly higher. The higher sampling resolution
in this cases will possibly compensate for the SNR loss proposed by Li et al.
(2012) caused by parallel imaging. The significant differences for certain PAT
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factors on PF shown in this work are in accordance with Aerts et al. (2011)
and Ginsburg et al. (2016). This can be understood as the determination of PF
depends mainly on the initial slope of the tissue curve. In order to adequately
measure this rapid signal change, a high sampling rate is required. Other param-
eters such as PV are only determined in the further, slower changing progress
of the curve. To determine those properly it is rather important to keep the
measurement running until baseline is reached again. This issue should also
be considered in the context of the measurement of AIF which plays a central
role, especially in the application of pharmacokinetic models. A high temporal
resolution is required to cover the rapid signal change sufficiently. The spatial
resolution, on the other hand, is of less importance for the AIF measurement.
To ensure this high spatial resolution in tumor tissue, however, is of utmost im-
portance for diagnosis or therapy monitoring. Since the tissue curve progression
does not show any more extreme changes, especially after the first slope, the
sampling rate could be reduced and the spatial resolution increased instead. In
the CT routine, studies have already been performed with higher sampling rates
in the phase of AIF measurement and first pass in the tissue and lower sampling
rates when the remaining tissue signal is acquired. This was initially done in
order to reduce the dose (Sudarski et al., 2018). In MRI, however, it could be
a possibility to combine optimal AIF sampling and high tissue spatial resolution.
Finally, it has to be noted that all sampling resolutions used in this experi-
ment are high compared to other studies and clinical practice. The currently
minimal recommended range is Ts < 8 - 15 s (Aerts et al., 2011). An even
greater effect of the quantification quality can thus be expected with these long
Ts. Based on the results of this work, it can therefore only be recommended to
increase the sampling rate for DCE perfusion measurements, especially in the
first section of the acquisition. Especially when using pharmacokinetic models,
this could lead to a more reliable quantification of perfusion parameters.
Application for ASL
The feasibility of the phantom for perfusion measurements using ASL and a
comparison to the results obtained with DCE measurements was evaluated.
DCE models use numerous fixed parameters such as the HCT, relaxivity of the
CA and flip angle. They are affected by errors in their estimation which in
turn have a large influence especially on PF results (Tofts et al., 2012). But
Parkes and Tofts (2002) showed that also ASL is strongly dependent on the
chosen values for its model parameters as well. Cutajar et al. (2014) even asks
if both approaches can be compared at all having such different underlying
kinetic models and different intrinsic ways to measure perfusion. While ASL
covers short temporal windows, DCE acquisition lasts for several minutes. A
very simple phantom setup as proposed in this work could help to investigate
the comparability of those two methods more closely.
It could be shown that the phantom is suitable for ASL measurements, pro-
ducing homogeneous PF maps. The results of the ASL measurement of (98 ±
36) ml/100 ml/min are in good agreement with the DCE results of (91 ± 26)
ml/100 ml/min. Although, it needs mentioning that higher blood flow and a
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relatively low SNR will make the transition from phantom to patient approach
likely to be more complicated. This is one of the reasons why ASL has not yet
found broad clinical application. Now, for the development of a standardized
workflow, the two independent measurement methods can be compared. This
offers great potential in perfusion measurement and strengthens the importance
of both DCE and ASL. Balancing patients’ needs such as CA incompatibility
and diagnostic needs such as high resolution could thus easier be achieved.
Application for DCE CT
Due to radiation exposure during a CT scan, phantoms are important to de-
velop, investigate, and evaluate new perfusion imaging techniques. The feasi-
bility of the phantom for DCE CT measurements could be shown. Washout of
iodine based CA is similar to the one obtained by Gd in the MRI measurement,
its higher viscosity did not influence this process. This could be demonstrated
by a good agreement in the clearance fit parameter of KCT = 203 ml/min and
KMRI = 207 ml/min. AIF and tissue functions could be obtained and gamma
variate fits revealed comparable results to those achieved in the MRI measure-
ment. The delayed start in the AIF may be caused by a larger distance of CA
injection point and position of AIF measurement caused by a slightly changed
experimental setup in the scanner room. Another explanation could be the
higher viscosity of the CT CA leading to a changed fluid dynamic of the bolus.
PF = (94 ± 53) ml/100 ml/min obtained with the FD approach is in good
agreement with the MRI results (PF = (91 ± 26) ml/100 ml/min). The higher
standard deviation might be due to image artifacts caused by the tube with a
high concentration of CA next to the phantom which should be changed in the
phantom setup in future measurements. MTT as well shows a good agreement
whereas PV is reduced. The application of the alternative quantification ap-
proach could be the reason for this and remains further research.
Limitations - DCE Perfusion Phantom Study
One limitation of the phantom is the orientation of the fibers in a preference
direction. Physiologically, capillaries are branched in arbitrary directions. This
has an effect on the measured total signal in a slice which cannot be reflected
by the dialyzer phantom. Gaass et al. (2017) developed a phantom providing
a solution for this, however, it is not reproducible in its production and com-
partments can not be modeled. The development of ever more precise and
refined 3D printing methods may be a conceivable solution to combine both
the reproducible and branched capillary approaches in the future.
The use of water as a transport medium for the CA ensured optimal repeata-
bility and control of the experimental conditions. However, it is expected that
the flow dynamics in the in vivo capillaries will be more complex than in our
experiments as a result of the pulsating flow in the arterial vessels and the non-
Newtonian behavior of the blood. In other studies, flow dynamics have already
been simulated with a water glycerol mixture, which is closer to the composition
of blood (Foltz et al., 2019). Yet, this is more cost-intensive and the behavior
within capillary-sized fibers in phantoms would have to be examined first.
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5.2 DCE in Vivo Study in Rectal Cancer
Patients
Bilateral Blood Supply and AIF selection
It is essential to determine a reliable AIF for the quantification of perfusion
as completely different physiological processes can lead to the same tissue sig-
nal. Calamante (2013) describes an example of a narrow bolus, which reaches
the tissue very quickly but leaves it slowly and with a long MTT due to a hy-
poperfusion of the tissue. The study compares this with a slow and wide bolus
that leaves the tissue quickly and with a shortened MTT due to hyperperfusion.
Both scenarios would provide similar tissue curves and thus perfusion parameters
although the tissue condition has completely different physiological pathologies.
This finding is in contrast to the clinical practice. Mostly, qualitative or semi-
quantitative evaluation of the tissue curve is done. If sometimes quantification
with a pharmacokinetic model is performed, an AIF in one slice and on one
side of the body is arbitrarily selected only. To examine this topic in more de-
tail, the effects on the perfusion parameters were investigated in rectal cancer
patients. Either the left or right supplying artery was used as AIF and the in-
fluence when using a model free FD approach and two dual CM were compared.
Differences in the signal obtained with left and right AIF were observed. Signif-
icant deviations for some of the resulting perfusion parameters were found for
the 2CX and 2CU, but not for the FD approach. A closer look at the individ-
ual patients revealed heterogeneous results among them. Some of the patients
show little or no dependence on the selected side of the AIF, others show large
inconsistencies with deviations in the PF of up to 30 ml/100ml/min. These
findings are in agreement with studies of the influence of the AIF selection of
quantification in DCE MRI in other organs (Cutajar et al., 2010).
An explanation could be of a physiological nature. After the bolus is injected
into a peripheral vein, it passes through the heart and lungs before being dis-
tributed in the tissue. Along the entire way, the bolus may be altered in different
ways on either side of the body. If bolus delays occur, the temporal offset be-
tween AIF and tissue function no longer displays the reality. Furthermore, the
bolus can be broadened by diffusion, an effect called dispersion. Since the stud-
ied patients are severely ill or elderly people, abnormal changes in the arteries
due to stenosis or occlusions are not uncommon and can alter the bolus even
further (Michaely et al., 2006). Several correction methods have been proposed
for these problems (Calamante et al., 2000). However, most of them are elabo-
rate to implement and time consuming to use. This makes them less applicable
in clinical practice. A more feasible solution is to choose the artery as close as
possible to the tissue. However, these arteries are already divided into several
branches and are small in diameter. Partial volume effects can therefore occur
in the selected ROI. These can lead to considerable changes in the AIF in both
peak width and height (Calamante, 2005).
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As a first compromise that is easily implemented in clinical practice, both the
left and the right artery were examined as close as possible to the tumor. The
two results were averaged and the resulting AIF applied to obtain quantitative
perfusion results. In this way larger deviations due to the above mentioned
conditions could be attenuated.
Compartment Models and Model Free Approach
Several studies showed that the determination of perfusion parameters can serve
as an additional tool for diagnosing and staging pathological changes of organs
and subsequently finding an appropriate therapy method (Attenberger et al.,
2014; Ceelen et al., 2006). A variety of models for the calculation of these
parameters is available but there is no consensus which model represents the
parameters best. Thus, it is important to use the most accurate model for
determination of robust functional parameters to help establish their additional
value for diagnostic imaging. In this study, we investigated three different tracer
kinetic approaches, the model-free FD approach, the 2CU and the 2CX model,
and their impact on the quantitative perfusion parameters for rectal cancer.
The use of pharmacokinetic modeling on DCE MRI data from rectal cancer pa-
tients is in contrast to previous studies that mainly dealt with the FD approach
(Attenberger et al., 2014) or the Tofts model (Tong et al., 2015).
Mean values of the calculated quantitative perfusion parameters (PF, PV,
MTT) show that they depend on the specific evaluation approach and are
influenced by the tracer kinetic model. Perfusion values in patients differ more
between the deconvolution and compartment models than among the compart-
ment models which could be visualized in the Bland Altman plots. These results
are in accordance with findings by Sourbron and Buckley (2011), where an un-
derestimation of MTT and PV is described for the model-free analysis. This
underestimation can occur due to long interstitial transit times of extravascular
tracers. It is associated with an underestimation of the area under the impulse
response function caused by too short acquisition times. They also reported a
possible underestimation of PV for the extended Tofts model, whereas this ef-
fect does not occur for the compartment models (Sourbron and Buckley, 2013).
This could be an argument for the use of the 2CM as opposed to the Tofts
model. As the 2CU is a simplification of the 2CX for specific physiological
cases, both models should yield similar results in these cases, whereas outliers
would occur only if one of the model includes effects that the other model does
not consider and thus fits the patient’s perfusion data better. This is supported
by the fact that, on the one hand, more outliers are detected for the compar-
ison of the dual compartment models. On the other hand, standard deviation
is smaller in contrast to the comparison with the FD approach. Permeability
parameters are significant higher for the 2CU compared to the 2CX. These are
the parameters that describe the exchange characteristic between the two com-
partments, which is expected to be different in the 2CU than in the 2CX. The
results may therefore indicate that one of the models better describes the true
physical condition. However, due to the small patient number and the lack of
a gold standard measurement, further conclusions are difficult to draw. The
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significant differences of the AIC and χ2 values as a measure of the goodness
of fit may be described by a few single outliers, as mean values show similar
results. Most patients were grouped in T3 cancer stage. Thus, too few patients
in cancer stages T2 and T4 were available to draw any conclusion on whether
the stage correlates with the mean perfusion parameters. Yet, this hypothesis
shall be investigated in future clinical studies.
A comparison with previously published papers investigating DCE MRI of rectal
cancer is challenging as a majority of studies used only the Tofts model for eval-
uation, which does not enable the quantification of the perfusion parameters
examined here (Ceelen et al., 2006; Tong et al., 2015). The 2CM considered
here have not been employed for the calculation of perfusion parameters in rec-
tum cancer MR images before. However, studies using CT perfusion data show
blood flow values between 60 and 110 ml/100ml/min which corresponds to a
PF of 33 and 60.5 ml/100ml/min, respectively, and is thus in a good agree-
ment with the values we obtained in our study (Goh et al., 2008; Sahani et al.,
2005). Calculated perfusion values for healthy rectum tissue showed higher
PF and PV for all models which is also in good agreement with Sahani et al.
(2005). However, due to the small size of the healthy rectum wall, only data
of 10 patients was evaluated and the amount of pixels used was quite small.
This could be an explanation why we measured longer (FD/2CU) or constant
(2CX) MTT whereas in Sahani et al. (2005) it is reported to be shorter. Since
the goodness of fit and perfusion parameters show reasonable results, it can be
assumed that the dual compartment models used are generally suitable for the
quantification of perfusion in rectal cancer. The choice of the optimal model
depends on several aspects, for instance, if only the perfusion has to be de-
termined or if further information such as permeability and interstitial volume
are to be studied. In Donaldson et al. (2010) guidelines on selecting a tracer
kinetic model are given. These guidelines state out that in some cases the 2CX
and 2CU model provide advantages compared to the commonly used models.
First of all, additional parameters can be useful for clinicians to describe the
tumor and help to decide which therapy to use. Especially for antivascular
drugs and a pre- and post-treatment observation, the FD approach cannot give
any information as it does not describe two compartments and the parameter
Ktrans of the Tofts model is not as specific as PF and PSAP in the 2CX model.
Furthermore, the Tofts model assumes that the time taken for the CA to pass
through the plasma compartment (plasma MTT) is negligible. However, calcu-
lated MTTs show, that this cannot be assumed and signalize that the 2CX or
2CU model could describe the data better. Imaging quality is sufficient to use
a more complex model than model free FD approach, which is probably more
robust for images with poor data quality but does not describe the physiology
properly (Luypaert et al., 2011; Sourbron and Buckley, 2011).
We found significant differences between all three approaches. This indicates
that there is not only one appropriate model for the complete patient cohort,
but some models seem to fit better to some specific patients. An investigation
on whether a specific tumor condition or stage is decisive for the choice of the
model sounds promising. However, the investigated patient cohort is limited
with 18 patients. A larger number of experimental studies to show repro-
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ducibility and validity of the parameter values would be necessary for a general
statement on clinical usefulness and whether one model should be prioritized
over the other. Whether general statements can be made for one type of tumor
or if the best possible model can also differ from patient to patient remains
questionable. The work of Romain et al. (2017), which proposes a framework
for model estimation based on physiology, imaging quality and further parame-
ters, seems promising. Nonetheless, the potential of other, physiologically also
appropriate models compared to the widely used ones and the strong depen-
dency of quantitative perfusion parameters on the chosen model could be shown
here.
2D and 3D Evaluation
This study demonstrates that perfusion parameters obtained only in a single
slice selected by physicians in clinical routine may differ greatly from the mean
values derived in a whole tumor volume. The difference between minimum and
maximum values within a volume is even more severe with up to 28% for PF
and PV and 36% for MTT. The study was limited to only five of the 18 patients
because the image quality of the remaining ones was not sufficient for a volume
evaluation. Therefore the meaningfulness of the results can be transferred to all
patients only to a limited extent. However, the findings are in accordance with
other studies of Davenport et al. (2013); Goh et al. (2008); Mendichovszky et al.
(2009) that have not investigated different slices, but determined the influence
of the size of AIF and tissue ROI. Goh et al. (2008) compared tissue ROIs in
rectal CT images with respect to their size. The study concluded that there is
a huge influence on the perfusion values. It was pointed out, that especially
on the edges, the homogeneity of the tumor perfusion is not given anymore.
Davenport et al. (2013) observed in a study of simulated data that inter reader
reproducibility was highest, when the largest possible ROI in one tissue slice is
chosen. Mendichovszky et al. (2009) observed the ROI size of AIFs in kidney
DCE MRI highly influences the perfusion parameters. Taken all these findings
and the results obtained in this thesis together, the selection of ROIs in both
AIF and tissue plays a major role in perfusion quantification. There are two
main influences: First, the acquired signal contains partial volume or inflow
artifacts. Due to poor selection of the AIF, the artifact can distort the signal in
the ROI leading to incorrect results. Second, the signal in the respective ROI
is different for anatomical or physiological reasons. The latter one advises that
due to the heterogeneous morphology of most tumors, the evaluation of perfu-
sion parameters of the entire tumor for analysis seems mandatory to determine
different degrees of tumor vascularity, necrosis or hemorrhage. Although there
are also other proposed correction methods, such as the omission of the tumor
margin, the practical implementation of this procedure is somewhat arbitrary
and therefore strongly dependent on the person evaluating the data. Addition-
ally, the problem with recommended methods of selecting the presumed correct
ROI is that there is no gold standard to compare the results to. Choosing the
entire tumor volume in the first place increases the clearness in the definition
of the volume of interest whereas individual slice selection suffers from intra
observer variance. In summary, a recommendation to determine 3D perfusion
parameters can be made, especially if volume data is already available and can
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thus contribute to a more targeted therapy.
Comparison DCE CT
The DCE CT perfusion measurement is also feasible as a comparative modality
or alternative in case of contraindication of an MRI measurement. It is there-
fore relevant whether comparable results can be achieved in a quantification.
Kierkels et al. (2010) performed DCE MRI and CT perfusion parameters of rec-
tal tumors with the Tofts model. They found similar results for Ktrans, however
could not find any correlation between ve and vp comparing both modalities.
Although the scanner is of an older generation and the model used was a dif-
ferent one, the results seem to be in agreement with this study. PF values lie
within the 1σ confidence interval, however PV and MTT differ significantly. A
reasons may be the different viscosity of the CA, the effect could be overcome
with a calibration of both. Additionally, total acquisition time in this study
was only 30 s due to dose restriction. PF, which is mainly determined by the
first part of the tissue curve, is therefore more accurate than PV and MTT,
determined from the latter part of the tissue curve for which the measurement
did not last long enough (Cuenod and Balvay, 2013).
Limitations - DCE In Vivo Study in Rectal Cancer Patients
Signal evaluation A general concern regarding DCE MRI is a lack of stan-
dardization concerning image acquisition routines and evaluation of obtained
data. The combination of different factors such as insufficient coverage of
the entire tumor volume, varying type and amount of CA, arbitrary slice se-
lection regarding AIF or tumor or the application of different model functions
and methods for analysis complicates the comparison among different studies
(Khalifa et al., 2014). In this study, the choice of AIF and tumor slice followed
the orientations used in previous studies and was strictly adhered to for all an-
alyzed patients, guaranteeing best possible reproducibility (Fusco et al., 2011).
Further improvement could be achieved by whole tumor analysis, accomplished
by using the applied 3D sequences for tumor volume rendering, which would
account for heterogeneous tumor tissue.
Gold standard A limitation of the study is that no gold standard method
for measuring the perfusion parameters, e.g. scintigraphy or positron emission
tomography was employed and compared to the models. However, the quan-
tification methods were compared to each other rather than producing absolute
values. As outlined before, the obtained values are found to be in the same
range compared to other studies.
Motion artifacts No correction of motion artifacts was performed. Peri-
staltic movement in the abdominal region can lead to wave-like deviations in
the obtained data and might have an influence on the results. However, as all
methods were applied to the same DCE MRI data sets, any occurring motion
artifacts would have affected the results equally and were not considered a major
cause of error. Image registration approaches aiming to reduce motion artifacts
in DCE MRI exams of rectal cancer should be considered in prospective studies.
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Scanner The study used two different scanners to obtain the patient data.
However, the exact magnetic field strength given for both scanners Magnetom
Skyra and Magnetom Trio is B0 = 2.89 T. Furthermore, a study investigated
diffusion values at these two scanners previously, and came to the conclusion
that nearly identical values could be obtained (Rao et al., 2012). Together
with the fact that all other parameters are comparable and when calculating
perfusion parameters, the baseline signal is subtracted, we assumed that the
influence of the scanner difference is negligible.
General Limitations
CA Concentration No conversion of signal intensities to CA concentration
was performed, but a linear relationship was assumed. As the conversion from
signal intensities to CA concentration is performed before the application of the
pharmacokinetic models, this can be regarded as a systematic error. It should
have a similar effect on all methods and consequently it would not change the
comparison presented in this work. For a more precise conversion of the mea-
sured signal into the concentration, the variable flip angle (VFA) method is
used to initially quantify the measured T1 value. From this, the concentration
can be calculated via a linear relationship between T1 and the concentration
(Dickie et al., 2016). In some studies, an improved accuracy and precision
has been shown by VFA application (Dickie et al., 2016; Dietrich et al., 2015)
and therefore seems to be recommendable. However, these results are based
on synthetic data and phantom measurements. In the above-mentioned work,
corrections in homogeneity were first carried out on the B1-field for the pre-
cise quantification of T1 values. Together with the VFA measurement itself,
this results in a considerably longer measurement time, which is not easily ac-
ceptable for the patient. In addition, the acquired perfusion image has to be
registered with the measured correction image afterwards. The method has also
been applied in the human brain (Cheng and Wright, 2006), but in contrast
to DCE measurements in the abdomen, fewer motion artifacts are produced
and the measurement time is shorter in general. Correction measurements and
application are therefore more justifiable in terms of time and are more realistic
to perform. Nevertheless, the influence of conversion of signal intensities to
CA concentration curves appears to be a contributing factor and needs to be
examined in future research.
Software Studies have found that the reproducibility and accuracy of pharma-
cokinetic parameter measurements depend on the software package used. The
studies of Beuzit et al. (2016) and Kudo et al. (2010) investigated different
software for CT and MR and used the same source data for evaluation. Signif-
icant errors of up to 80% were found in the calculated pharmacokinetic DCE
parameters, resulting in poor comparability. Different curve fitting algorithms,
the definition of the AIF, namely patient- or population-based (Rata et al.,
2016) for MRI and the tracer delay sensitivity in CT was given as main reasons.
It would explain the difference between the rectal CT and MRI data compared
in this thesis. Also deviations between values of this study and literature for
the MR rectal perfusion parameters may have attributed to this.
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Ethics and new studies The findings from both the phantom and retrospec-
tive rectal cancer study have not yet been applied to humans in a new study
or in clinical practice. Compared to other procedures in MRI, which can be
tested immediately on volunteers, a volunteer or even patient study is ethically
not easily feasible due to the necessary administration of CA. Diseases of the
kidney or an allergy to one of the CA components even completely exclude
such an examination or it may only be carried out in an absolute emergency.
The critical use of CA has been further strengthened by studies in recent years,
which have observed that CA can be accumulated permanently in the brain
and cause damage (Montagne et al., 2016; Taheri et al., 2016). Alternative
techniques are DCE CT as described in this thesis or MRI perfusion measure-
ments with ASL. However, there are pitfalls here as well. The time-resolved
CT performed with modern devices has a lower dose than previously and is
therefore feasible in general. But the accumulated dose is not negligible, espe-
cially in follow-up examinations. In addition, CA must be administered here as
well, which in turn can lead to allergic reactions. The ASL measurement does
not require any irradiation or CA at all, but due to the low signal a reliable
quantification is not yet possible, especially in the abdomen. In summary, this
encourages even more the development of valid human-like perfusion phantoms.
With these, novel and improved methods can be developed and evaluated most
effectively, making a transfer into clinical routine ethically justifiable. A phan-
tom as presented here, applicable for simultaneous use with all three methods
(DCE MRI, DCE CT and ASL) allowing comparisons among each other can
set the standard for the selection of the most suitable method for each indi-
vidual patient case while always achieving the same reliable, quantifiable results.
Clinical Transfer and Future Directions
A first step for data acquisition would certainly be to establish a consistent ac-
quisition protocol. Such a standardized procedure has already been suggested in
(Shukla-Dave et al., 2019). For the future, a more frequent adaptation of this
protocol on the basis of advancing research results would be desirable. This
would also make a comparison of retrospective data with one another much
easier with regard to further development of the evaluation methods. How-
ever, in all performed experiments the main uncertainty factor is the manual
and individual selection of evaluation methods. Study results thus are always
dependent on the physicians, on their qualification and the consideration that
a comprehensive selection means a large investment of time, which is unrealis-
tic in clinical routine. However, for the measurement reproducibility and inter
and intra site quality consistency and thus a robust quantification is inevitable.
Ideally, a fully evaluated 4D data set of the possible AIF arteries and the tissue
to be examined should be available. At best, a suitable model is automatically
selected on this basis and under consideration of the physiological parameters.
Based on the development in recent years, the use of neural networks for this
issue is an obvious choice. Accordingly, further studies (Tönnes et al., 2020)
have been started based on this work.
Conclusion6
The quantification of tissue perfusion MRI is of great medical value for tumor
diagnosis, treatment planning and therapy control yielding information about
blood supply to organs and tumors non invasively. However, quantitative dy-
namic perfusion measurements are not yet fully established in the clinical rou-
tine. Reproducibility and comparison of quantitative parameters is difficult due
to non-standardized examinations and data analysis.
The objective of this work was to evaluate the feasibility and to find improve-
ments and limitations of Dynamic Contrast Enhanced (DCE) MRI in combi-
nation with pharmacokinetic modeling for perfusion quantification. To achieve
this, two approaches were pursued.
In the first part, a multimodal perfusion phantom mimicking tissue at the cap-
illary level was developed to investigate the reproducibility of perfusion parame-
ters. In contrast to other phantoms, the phantom possesses two compartments
that simulate intra- and extravascular space and thus better reflects human
physiology. This enabled the application of a dual compartment model which
allows the modeling of perfusion and permeability. Reproducible values both
within repetitions of a series of measurements and in the repetition after one
week were obtained. DCE MRI phantom results could be compared to those
measured with Arterial Spin Labeling and DCE computer tomography, consis-
tent results were achieved. The standardized setup enabled an investigation
of an increased sampling rate on quantitative parameters. It could be shown
that the signal deficit due to the used parallel imaging technique can be com-
pensated by the higher sampling rate of AIF and tissue function. Significant
influence on the fit quality and perfusion parameters and a reduction of intra
measurement deviation could be shown in this case.
In the second part, the clinical evaluation of an in vivo perfusion study of
rectal carcinomas was investigated and further developed. The bilateral selec-
tion of the arterial input function and the use of dual compartment models
(Exchange and Uptake model) as well as tissue ROI selection in a heteroge-
neous tumor showed a significant influence on the quantification of perfusion
parameters. The determination of permeability parameters enabled by pharma-
cokinetic modeling can provide additional information about the extravasation
compared to model free approaches.
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Summarized, the significant influence of pharmacokinetic modeling, AIF and
tissue ROI selection and sampling rate on perfusion and permeability parame-
ters could be demonstrated by a phantom and in vivo study. To ensure reliable
quantification of DCE perfusion measurements in clinical routine, it will be es-
sential in the future to initially extract and analyze all the small individual steps
required in this context. Moreover, it will be necessary to identify the most
suitable methods according to the state of the art and finally to combine them
in a standardized form to a consistent measurement and analysis procedure.
The combination of phantom and in vivo studies is an effective solution to
jointly develop new strategies for the quantification of DCE MRI in the future.
A prime example could be the implementation of neural networks. Data pro-
vided from simulations, phantoms and patient studies can be incorporated into
neural networks. The gained knowledge could be of considerable benefit to this
research topic.
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